US20050084516A1 - Process for making gel films - Google Patents

Process for making gel films Download PDF

Info

Publication number
US20050084516A1
US20050084516A1 US10/824,689 US82468904A US2005084516A1 US 20050084516 A1 US20050084516 A1 US 20050084516A1 US 82468904 A US82468904 A US 82468904A US 2005084516 A1 US2005084516 A1 US 2005084516A1
Authority
US
United States
Prior art keywords
film
temperature
molten composition
gel
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/824,689
Inventor
Arthur Ballard
Christopher Sewall
James Modliszewski
William Blakemore
Peter Riley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FMC Corp
Original Assignee
FMC Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FMC Corp filed Critical FMC Corp
Priority to US10/824,689 priority Critical patent/US20050084516A1/en
Publication of US20050084516A1 publication Critical patent/US20050084516A1/en
Assigned to FMC CORPORATION reassignment FMC CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MODLISZEWSKI, JAMES J., BALLARD, ARTHUR D., BLAKEMORE, WILLIAM R., RILEY, PETER J., SEWALL, CHRISTOPHER J.
Priority to US11/954,958 priority patent/US20080089934A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/238Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seeds, e.g. locust bean gum or guar gum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11Encapsulated compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/737Galactomannans, e.g. guar; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Definitions

  • the present invention is directed to a process for making homogeneous, thermoreversible gel films comprising the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally, de-aerating a film forming composition in an apparatus providing sufficient shear, temperature and residence time to form a homogeneous molten composition, wherein the temperature is at or above the solubilizing temperature of said composition; (ii) feeding the molten composition into at least one of a mixer, pump or devolatilizer; and (iii) cooling the homogeneous molten composition at or below its gelling temperature to form said gel films.
  • the present invention is also directed to various products made from such films, such as the gel films themselves, soft capsules, solid dosage forms and delivery systems.
  • compositions containing, for example, hydrocolloids form highly viscous solutions that make formation of hydrated films difficult to obtain.
  • the present invention provides a process for preparing high solids, low moisture films from such highly viscous solutions.
  • the present invention is directed to a process for making homogeneous, thermoreversible gel films comprising the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally, de-aerating a re film forming composition in an apparatus providing sufficient shear, temperature and residence time to form a homogeneous molten composition, wherein the temperature is at or above the solubilizing temperature of said composition; (ii) feeding the molten composition into at least one of a mixer, pump or devolatilizer; and (iii) cooling the homogeneous molten composition at or below its gelling temperature to form said gel films.
  • the present invention is directed to the homogeneous, thermoreversible, gel films made from the above process.
  • the present invention is directed to a process for making soft capsules comprising the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally, de-aerating a film forming composition in an apparatus providing sufficient shear, temperature and residence time to form a homogeneous molten composition, wherein the temperature is at or above the solubilizing temperature of the composition; (ii) feeding the molten composition into at least one of a mixer, pump or devolatilizer; (iii) cooling the molten composition to or below the solubilizing temperature of the molten composition to form the homogeneous, thermoreversible gel film; and (iii) making soft capsules from the gel film.
  • the present invention is directed to soft capsules made by the above process.
  • the present invention is directed to a process for making a solid dosage form comprising a fill material encapsulated by a homogeneous, thermoreversible gel film comprising the steps of: (i) preparing the homogeneous, thermoreversible gel film in accordance with the above process; and (ii) encapsulating the fill material in the gel film.
  • the present invention is also directed to solid dosage forms made from the process.
  • the present invention is directed to a process for preparing a homogeneous gel film delivery system comprising an active substance and a homogeneous, thermoreversible gel film, comprising the steps of: (i) preparing the molten composition in the above process; (ii) adding an effective amount of an active substance prior to or after formation of the molten composition: and (iii) cooling the molten composition containing the active substance at or below its gelling temperature to form the gel films containing the active substance.
  • the present invention is also directed to delivery systems made by the process.
  • the present invention is directed to a process for making homogeneous, thermoreversible gel films comprising the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally de-aerating a film forming composition in an apparatus providing sufficient shear, temperature and residence time to form a homogeneous molten composition, wherein the temperature is at or above the solubilizing temperature of the composition; and (ii) cooling the homogeneous molten composition at or below its gelling temperature to form said gel films.
  • the present invention is also directed to dosage forms, solid forms and delivery systems made by the process.
  • Figure 1 is schematic of a process of the present invention to make films and soft capsules using a Stephan processor together with an extruder.
  • the extruder is optional in this figure, and the Stephan processor can be replaced with, e.g., a Ross mixer.
  • this figure refers to "LV Guar” (low viscosity guar), this invention is not limited thereby.
  • Figure 2 is a schematic of a process of the present invention to make films and soft capsules using a fluid mixing apparatus such as in Figure 3 together with an extruder.
  • the extruder is optional in this figure.
  • Figure 3 is a partially broken away, side elevational view of the fluid mixing apparatus for mixing first and second fluids with steam that can be used in the process of Figure 2.
  • Figure 4 is another version of the schematic of Figure 2 showing the film coming out of the extruder proceeding to an encapsulation apparatus.
  • a first embodiment of the present invention is a process for making homogeneous, thermoreversible gel films comprising the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally, de-aerating a film forming composition in an apparatus capable of providing sufficient shear, temperature and residence time to form a molten composition, wherein the temperature of the molten mass is maintained at or above its solubilizing temperature; (ii) feeding said molten composition into at least one of a mixer, pump or devolatilizer; and (iii) cooling said molten composition at or below is gelling temperature to form said gel films.
  • the process of the present invention provides homogeneous, thermoreversible gel films having, e.g., a relatively high solids content.
  • homogeneous film defines films that, to the naked eye, are visually uniform and free of defects such as lumps, cracks, particles that are undissolved that should be dissolved, non-uniform distribution of insoluble particles, etc. "Fish eyes” (mixed liquid and solid states) or “gel balls” (non-uniform gel structure) would not meet the definition of "homogeneous” as used herein.
  • the gel films of the present invention are homogeneous, thermoreversible gel films. They can be cast and used in a variety of applications as cast films or in further processing.
  • thermaloreversible film defines a film that has a melting temperature.
  • the melting temperature is the temperature or temperature range over which the gel film softens or flows.
  • gel films refer to a thin membrane formed from, e.g., structured hydrocolloid.
  • the gel-forming composition is characterized by a gel temperature, the temperature below which the molten mass of the gel composition must be cooled to form a self-supporting structure.
  • a molten mass can be cast hot and allowed to cool, as well as dry to further concentrate the solids (controlled moisture removal) until a gel film is formed by the gel composition.
  • the melt temperature of a thermoreversible gel film is higher than its gel temperature.
  • the "solubilizing temperature” means the temperature at which the composition becomes homogeneous. Solubilizing refers to the act of fully dissolving all the soluble components in the molten composition and all insoluble materials are uniformly dispersed.
  • the components in the film forming system can be any components found in film forming compositions that form high solids, low moisture gel films when heated and hydrated and that form homogeneous, thermoreversible gel films.
  • such compositions can contain thermoreversible hydrocolloids.
  • thermoreversible hydrocolloids that can be used in the present invention to form thermoreversible gel films include polysaccharides such as: carrageenan including iota carrageenan, kappa carrageenan, kappa-2 carrageenan; xanthan gum; polymannan gums (e.g., glucomannan gums and galactomannan gums) such as locust bean gum, konjac, tara gum, cassia gum, guar gum (e.g.
  • low viscosity guar gum low viscosity guar gum
  • alginates including propylene glycol alginate and monovalent salts of alginates such as potassium and sodium
  • pullulan propylene glycol alginate and monovalent salts of alginates such as potassium and sodium
  • pullulan propylene glycol alginate and monovalent salts of alginates such as potassium and sodium
  • gellan including high and low-acyl gellan
  • dextran including high and low-acyl gellan
  • pectin and combinations thereof.
  • the carrageenans can be modified, less than fully modified or unmodified.
  • kappa-2 carrageenan has a molar ratio of 3:6-anhydrogalactose-2-sulfate (3:6-AG-2-S) to 3:6-anhydroglactose (3:6-AG) content of 25 to 50%
  • iota carrageenan has a molar ratio of 3:6AG-2S to 3:6AG content of 80 to 100%
  • kappa carrageenan has a molar ratio of 3:6AG-2S to 3:6AG content less than that for kappa-2 carrageenan.
  • kappa carrageenan from Eucheuma cottonii a commonly known and used seaweed source for kappa carrageenan
  • iota carrageenan from Spinosum a commonly known and used seaweed source for iota carrageenan
  • kappa-2 carrageenan comprises a ratio of kappa (3:6-AG) repeating units to iota (3:6-AG-2-S) repeating units between 1.0 to 3.0:1, more particularly, 1.5 to 3.0:1 (more particularly depending on the desired application).
  • the molar ratio of 3:6AG-2S to 3:6AG content in these carrageenans holds regardless of its degree of modification and precursor content (e.g, mu and nu repeating units).
  • the homogeneous, thermoreversible gel film made by the process of the present invention can optionally contain at least one of a plasticizer, a second film former, a bulking agent and a pH controlling agent depending on their application.
  • plasticizers examples include polyols such as glycerin, sorbitol, maltitol, lactitol, corn starch, fructose, polydextrose, solubilized oils and polyalkylene glycols such as propylene glycol and polyethylene glycol.
  • plasticizers can generally be used in an amount of at least 5%, more preferably, at least 10%, more preferably, at least 20%, more preferably, at least 30% by weight of all the components including water in the dry film if a gel film having more elasticity is desired; e.g., films to be used to make soft capsules.
  • the plasticizer can be present in an amount of 0% to 20% by weight of all the components in the dry film. It is possible that the gel film of the invention contains no plasticizer at all.
  • the carrageenan can have a viscosity of 19 cps or less, more particularly less than 10 cps, at 75 °C when measured 0.10 molar sodium chloride solution containing 1.5% of such carrageenan by weight based on the total weight of the composition. This viscosity test can be performed using a Brookfield LVF (Brookfield Engineering Laboratories, Inc.) viscometer using Spindle #1 at 60 r.p.m. and determining the viscosity after six revolutions.
  • Brookfield LVF Brookfield Engineering Laboratories, Inc.
  • Examples of the second film former that can be used in the present invention include at least one of a starch, starch derivative, starch hydrozylate, cellulose gum, hydrocolloid, an alkylcellulose ether or a modified alkyl cellulose ether.
  • Examples of the hydrocolloids are those listed above. Others include non-gelling carrageenans such as lambda carrageenan.
  • An example of an alkylcellulose ether that can be used in the present invention is hydroxyethylcellulose.
  • Examples of modified alkylcellulose ethers that can be used in the present invention include hydroxypropylcellulose and hydroxypropylmethylcellulose.
  • the primary film former can be the only film former in the gel film. When the gel films of the present invention contain second film formers, the primary film former can be present in an amount of at least 10%, at least 40%, at least 60% or at least 80% by weight of the total amount of film formers in the gel film.
  • modified starch includes such starches as hydroxypropylated starches, acid-thinned starches, and the like.
  • modified starches that can be used in the present invention include Pure Cote? B760, B790, B793, B795, M250 and M180, Pure-Dent? B890 and Pure-Set? B965, all available from Grain Processing Corporation of Muscatine, Iowa, and C AraTex? 75701, available from Cerestar, Inc.
  • modified starches are products prepared by the chemical treatment of starches, for example, acid treatment starches, enzyme treatment starches, oxidized starches, cross-bonding starches, and other starch derivatives. It is preferred that the modified starches be derivatized wherein side chains are modified with hydrophilic or hydrophobic groups to thereby form a more complicated structure with a strong interaction between side chains.
  • the amount of the bulking agent to be used in the present invention is generally in the amount of 0 to 20% by weight of the dry film, but more can be used, if desired, for example, at least 20%, more preferably, at least 30% of the dry film depending on the application.
  • starch, starch derivatives and starch hydrozylates can be multifunctional. That is, in addition to being used as bulking agents, they can be used as second film formers. When such are used as bulking agents and second film formers, they are generally used in an amount of at least 10%, preferably, at least 20%, by weight of the gel film.
  • Examples of the pH controlling agent to be used in the present invention include bases such as hydroxides, carbonates, citrates and phosphates.
  • the pH controlling agent can be chosen as the source of added beneficial cations such as potassium.
  • the pH controlling agent can be used to improve the stability of the gel film.
  • the amount of the pH controlling agent is generally in the amount of 0 to 4%, preferably, 0 to 2%.
  • the dry films made from the gels of the present invention have been found to have, for example, a break force of at least at least 1,000 grams, at least 2,500 grams, at least 4,000 grams, at least 5,000 grams, at least 6,000 grams, as determined by using a Texture Analyzer TA-108S Mini Film Test Rig.
  • wet films made by the process of the present invention have yielded low break force strength (e.g., 250-320g), but have produced strong dried films having the break force strengths mentioned above.
  • the gel films of the present invention have been found to have a solids content of at least 50%, at least 60%, at least 70%, at least 80% and at least 90% of all components in the gel film. It is understood that up to 15%, 10%, 5% water may remain strongly associated with the solids in the gel film.
  • Dry film thicknesses generally used for soft capsules are in the range of 0.5 to 3.0mm, more preferably, 0.8 to 1.2 mm.
  • the films of the present invention can contain nonthermoreversible gums.
  • nonthermoreversible gums should be present in an amount of less than 50% by weight of the thermoreversible film former, preferably, less than 40% more preferably, less than 30%.
  • nonthermoreversible gums include crosslinked or partially crosslinked gums such as calcium set (e.g., crosslinked) pectins or alginates. Calcium reactive alginates and pectins, as well as their less refined forms, are considered as thermoreversible gums in the absence of divalent cations.
  • the gel films of the present invention are generally made from a process utilizing an apparatus that enables sufficiently high shear, temperature (above the gelling temperature) and residence time so as to provide a homogeneous molten mass of the composition and formation of the gel upon cooling. This is generally accomplished in the apparatus by heating, hydrating, mixing, solubilizing and optionally de-aerating the composition.
  • Such apparatus include but are not limited to Ross mixers, Stephan processors, conventional jet cookers, extruders and the fluid mixing apparatus as set forth in Figure 3 . Ross mixers, Stephan processors, extruders and conventional jet cookers are readily available commercially.
  • the molten mass Prior to cooling, the molten mass can be fed to at least one of a pump, mixer or devolatilizer.
  • An extruded molten mass can also be directed to a film forming or shaping device (e.g. spreader box, as used in a capsule forming machine) that aids in the uniform casting of a continuous film, or, through a die that allows a direct formation of a film from the molten mass delivery equipment. Care must be taken to maintain the molten mass above the initiation of restricted flow/gel structure formation. Insulated and pre-heated (to maintain proper temperatures) transfer hoses may be used to insure molten mass flow until desired gel film formation is initiated on the casting rolls or at other film formation points, such as an extruder (restrictive flow, film forming device) or die.
  • a film forming or shaping device e.g. spreader box, as used in a capsule forming machine
  • Additional processing methods can force (by pressure) the molten mass through the transfer hoses mentioned above. Additional insulation can help maintain molten mass temperatures through the use of a Teflon disk initially placed upon the molten mass surface immediately after removing the mixing device.
  • the feeder hoses can be introduced to the heat controlled molten mass feeder (casting) boxes located on a capsule machine either directly to the boxes or through an optional modification of the feeder boxes which introduces a top half enclosure/cover that helps maintain molten mass temperatures within the feeder box, reduces moisture loss, and maintains uniform (center) filling of the box during the extended process of forming films for capsules.
  • molten mass temperatures can be used to form films for capsules. This includes, but is not limited to extrusion of the molten mass through dies/orifices into films that: can be immediately fed into the capsule forming apparatus, stored at temperatures that maintain proper film conditions (to form capsules) until needed, or dried to desired moisture, solids and texture levels, until needed.
  • Such dried films have the property of re-absorbing water (water is introduced by any means) throughout its gel film matrix and can be rehydrated when needed, for example, to make soft capsules or other solid forms. Moisture is introduced to the film until a desired moisture content and strength/texture is reached that will allow the film's introduction into a capsule machine to make soft capsules.
  • a typical process for using such with hydrocolloids is as follows.
  • the components of the film forming composition are fed into the Stephan processor and heated (while agitating) to a temperature, which provides solubility to the components above their gel temperature.
  • the material can then be processed into a gel film or as a molten mass. Further processing can be completed on this material while utilizing appropriate equipment to allow it to develop its final form.
  • FIG. 3 illustrates a fluid mixing apparatus 10 .
  • the fluid mixing apparatus 10 is arranged to mix steam 2 with a first fluid or slurry 4 and a second fluid or slurry 6 to produce a molten mass or slurry mixture 8 .
  • the fluid mixing apparatus 10 comprises a first housing 20 having a first inlet 22 through which the steam 2 enters the housing 22 , a nozzle end 24 from which the steam 2 exits the housing 20 , and a nozzle valve or stem 26 disposed at the nozzle end 24 .
  • An actuator means 30 is connected to the first housing 20 for controlling the exit rate or exit pressure of the first fluid 2 at the nozzle end 24 .
  • the actuator means 30 may be of the type manufactured by Fisher Controls U.S.A.
  • the fluid mixing apparatus 10 further comprises a second, mixing housing 40 coupled to the first housing 20 at the nozzle end 24 of the first housing 20 .
  • the second housing 40 includes a second inlet 42 through which the first fluid 4 enters the second housing 40 , and a third inlet 44 through which the second fluid 6 enters the second housing 40 .
  • the inlets 42 and 44 are disposed downstream of the first inlet 22 .
  • the second inlet 42 and third inlet 44 are disposed in a common plane and spaced apart radially from each other, most preferably directly opposite (i.e., 180o apart) about the central axis Y of the mixing apparatus 10 .
  • the second housing 40 defines a generally cylindrical mixing chamber 52 that in turn defines a flow passage extending along the axial length of the mixing chamber 52 from an entry end 54 of the mixing chamber 52 to an exit end 56 of the chamber 52 .
  • the nozzle valve 26 is movable by the actuator 30 between seated and unseated positions at the entry end 54 to control the flow rate of steam 2 into the mixing chamber 52 .
  • the nozzle end 24 of the first housing 20 directs the steam 2 into the entry end 54 of the mixing chamber 52 .
  • the second inlet 42 and the third inlet 44 radially direct the first fluid 4 and second fluid 6 , respectively, into the mixing chamber 52 .
  • the steam 2 , first fluid 4 and second fluid 6 are mixed in the mixing chamber 52 to form a molten mass or mixture 8 which exits the mixing chamber 52 .
  • the molten mass 8 then may be shaped into a shaped article or formed into a film, such as by casting the mixture 8 onto a cooling drum or by passing the mixture 8 through an extruder.
  • the molten mass composition may be then fed directly into at least one of a pump, mixer or devolatilizer. Then, the molten mass is cooled down to or below the gelling temperature of the composition to form the gel film.
  • solubilizing temperature be greater than the boiling point of the homogeneous molten composition at atmospheric pressure and that the heating, hydrating, mixing and solubilizing is conducted above atmospheric pressure.
  • a preferred process comprises feeding the molten composition directly into a mixer, deareated, depressurized and pumped prior to cooling to or below the molten composition's gelling temperature.
  • One device that contains at least one of a pump, mixer and devolatilizer is an extruder.
  • An extruder is preferred device for devolatilizing and thereby concentrating the solids of the molten composition prior to cooling.
  • Extruders that can be used in the present invention include single or dual barrel extruders with inlet devices sufficient to allow transfer of the fully or partially hydrated composition without incurring a temperature drop during the transfer. Once the compositional material achieves its targeted solids content and the temperature is maintained above its gel temperature, the resulting molten mass can be used as previously described.
  • the molten mass need not necessarily reach homogeneity in step (i). That is, homogeneity of the molten mass can be obtained prior to or after feeding the molten composition into at least one of the mixer, pump or devolatilizer provided the molten mass reaches homogeneity prior to gelling.
  • the present invention is a process for making soft capsules comprising the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally, de-aerating the film forming composition in the apparatus capable of providing sufficient shear, temperature and residence time to form a molten composition, wherein the temperature is at or above the solubilizing temperature of the molten mass; (ii) feeding the molten composition into an extruder to form a high solids, low moisture, homogeneous, thermoreversible gel film; and (iii) making soft capsules from the gel film.
  • the gel film and its components, as well as the apparatus and extruder that can be used, are as set forth above.
  • the process for making soft capsules of the invention includes the use of any conventional encapsulating apparatus once the gel films discussed are prepared, e.g., a conventional rotary die apparatus or concave stamping die.
  • a conventional rotary die apparatus or concave stamping die For example, once the molten mass of the present invention has been made, it can be cast onto drums, cooled and then fed between rotary encapsulation dies where the films are heated again, filled, sealed and cut.
  • WO 98/42294 see WO 98/42294.
  • the use of the high shear apparatus disclosed above allows the molten mass to be sufficiently hydrated, extruded, applied to drums as they are cooling and then fed into conventional encapsulating apparatus for filling, sealing and cutting. This continuous type process can be used to eliminate the step of having to reheat fully gelled and cooled films for capsule preparation.
  • Hard capsules refer to those solid forms that are conventionally used, e.g., in the pharmaceutical industry whereby two half shells are formed, a fill material, usually a powder, is placed in the shells and the two halves are placed together to form the hard capsule.
  • the process for making such hard capsules would typically involve dipping metal pins or bars into the molten composition of the present invention and allowing the gel film to form around the pins. The gel films are dried and then removed from the pins.
  • the fill materials for the hard capsules can be any fill materials commonly used in such dosage forms. Generally, the fill materials can be liquids or solids such as powders. The fill materials can be a pharmaceutical ingredient, agricultural ingredient, nutraceutical ingredient, veterinary ingredient, food, cosmetic ingredient, flavorant, etc.
  • the solid form may also encapsulate a powder, tablet, caplet, microcapsule or capsule in accordance with known techniques.
  • encapsulating a hard capsule with the gel film of the invention would allow for safety seal/tamper resistant capabilities.
  • gel films of the invention can contain added components that can create solid dosage forms having immediate release, controlled, enteric or delayed release capabilities. Definitions of "immediate release”, “delayed release” and “enteric” can be found in the U.S. Pharmacopeia and are incorporated herein by reference.
  • the gel films of the present invention can be used in a process for preparing a homogeneous gel film delivery system comprising an active substance and a homogeneous, thermoreversible gel film, comprising the steps of: (i) preparing the molten composition; (ii) adding an effective amount of an active substance thereto; and (iii) cooling said molten composition containing said active substance at or below its gelling temperature to form said gel films containing said active substance.
  • the active substance can include at least one of an oral care agent, a breath freshening agent, a pharmaceutical agent, a nutraceutical agent, a salivary stimulant agent, a vitamin, a mineral, a coloring agent, a sweetener, a flavorant, a fragrance, a food.
  • Process for making homogeneous, thermoreversible gel films of the present invention also comprises the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally, de-aerating a film forming composition in an apparatus providing sufficient shear, temperature and residence time to form a homogeneous molten composition, wherein the temperature is at or above the solubilizing temperature of the composition; and (ii) cooling the homogeneous molten composition at or below its gelling temperature to form said gel films.
  • This process can be used to make dosage forms, solid forms and delivery systems as mentioned above.
  • An apparatus especially suited for this process is the Ross mixer and, when making soft or hard capsules, can be used to provide the gel film directly to the capsule making machine or, if desired, to rollers for use at a later time. All of the materials described herein can be used in this process.
  • the following example uses the fluid mixing apparatus of FIG. 3 to make the gel films of the present invention.
  • Parts A and Parts B were pumped from separate holding tanks at ambient temperature, as two separate streams 4, 6, into two different inlet ports 42, 44 which fed the steam injection fluid mixing apparatus device 10.
  • the two individual streams 4, 6 were combined at the interface of the steam in the mixing zone 52 of the fluid mixing apparatus 10.
  • the separate solutions of Part A and Part B were readily pumped into the fluid mixing apparatus 10 and mixed with steam 2.
  • the steam 2 was introduced to the mixing zone at a pressure of 120 psi.
  • the resulting molten mass or slurry mixture 8 flowed out of the exit port 56 of the fluid mixing apparatus 10.
  • the mixture 8 was poured onto a smooth surface and drawn down to form a homogeneous film 9.
  • the molten mass 8 was collected from the outlet 56 then cast using a draw down bar, with a gap set at 3 mm, onto a stainless steel metal plate.
  • the initial films 9 or "fresh films” were collected. Portions of the fresh films 9 were dried by placing them in a 40oC forced air oven. Break force was measured on the cast and dried film strips using a Texture Analyzer TA-108S Mini Film Test Rig. The percent solids were determined by measuring the difference between the initial weight of the fresh film and the final weight of the dried films.
  • thermometer was inserted into the molten mass 8.
  • the material 8 was allowed to cool under room temperature conditions. After each degree of cooling, the thermometer was removed from the material 8. When a small, temporary indentation was observed in the surface of the mass 8, this temperature was recorded.
  • the thermometer was re-inserted into the mass 8, which was allowed to cool further.
  • the thermometer was removed and re-inserted at every degree of cooling until such a time as a permanent indentation formed in the mass 8, such that the indentation did not refill.
  • the temperature at which the permanent indentation formed was recorded.
  • the gel temperature reported was the range between the two recorded temperatures.
  • the components in the Tables below are further defined below in Tables 5 and 6.
  • Example No. 1A 1B 1C 1D 1E Part A (%) Carrageenan D 0.0 0.0 0.0 0.0 8.9 Carrageenan C 7.0 8.4 8.9 0.0 0.0 Carrageenan B 0.0 0.0 0.0 8.9 0.0 Glycerin 26.5 31.8 33.5 33.5 33.5 Part B (%) Starch 16.4 19.7 20.7 20.7 20.7 Water 50.0 40.0 36.9 36.9 36.9 Mixing chamber 107 107 108 108 temp. (° C.) Outlet temp (° C.) 101 102 102 102 102 Viscosity cP (@ 7300 5200 48000 50000 12400 95° C.) pH 7.3 Not tested 8 6.4 6.7 % solids 53 54 65 61 53 Gel temp.
  • Example No. 2A 2B 2C 2D 2E Part A (%) Carrageenan C 2.7 3.2 3.2 4.0 0.0 Carrageenan B 0.0 0.0 0.0 0.0 0.0 4.0 PGA 3.3 3.9 3.9 4.9 4.9 Glycerin 22.4 26.5 26.5 33.5 33.5 Part B (%) KOH 0.0 0.0 0.1 0.0 0.0 K 2 CO 3 0.0 0.0 0.0 0.3 0.3 Starch 13.9 16.4 16.4 20.7 20.7 Water 57.8 50.0 49.9 36.6 36.6 Mixing chamber 108 107 108 107 108 temp.
  • the film former can be a combination of hydrocolloids, such as carrageenan and PGA. Additionally, salts can be added to influence film properties such as strength, gel temperature and pH.
  • Example No. 3A 3B 3C Part A (%) Carrageenan E 0 4.0 4.2 Carrageenan B 4.3 0.0 0.0 ULV guar 4.6 4.9 5.1 Glycerin 33.5 33.5 27.0 Sorbitol 0.0 0.0 8.1 Part B (%) Starch 20.7 20.7 21.8 Water Mixing chamber temp. (° C.) 108 108 108 Outlet temp (° C.) 102 102 102 Viscosity cP (@ 95° C.) 7900 7800 69000 pH 6.5 5.6 5.5 % solids 57 57 55 Gel temp. (° C.) 60-65 >100 >100 wet film strength (grams) 460 3402 921 dry film strength (grams) 5299 6587 9234
  • Table 3 shows that the film former can be a combination of hydrocolloids such as carrageenan and guar.
  • Example No. 4A 4B Part A (%) Carragennan G 0.0 8.9 Carrageenan F 8.9 0.0 Glycerin 33.5 33.5 Part B (%) Starch B790 20.7 20.7 Water 36.9 36.9 Mixing chamber temp. ° C.) 108 108 Outlet temp (° C.) 102 102 Viscosity cP (@ 95° C.) >100K 8400 PH 7.5 8 % solids 46 49 Gel temp. (° C.) >100 >100 wet film strength (grams) 722 360 dry film strength (grams) 1095 4213
  • Table 4 illustrates that PES and upgraded PES can be processed in the mixing apparatus 10.
  • the upgraded PES provides some advantages, such as a lower outlet viscosity, and results in a higher strength dry film.
  • Tables 5 and 6 provide further descriptions of the components specified in this Example.
  • Carrageenan PES Kappa An alkali processed, non- FMC F clarified, processed Corporation Eucheuma seaweed product (containing kappa-carra- geenan) of Kappaphycus al- verezii( Eucheuma cottonii) with low di- valency.
  • the films made in accordance with this invention can be used in conventional capsule making equipment previously used for making gelatin capsules.
  • the Stephan UMC5 processor is a laboratory scale-mixing device which provided suitable high shear mixing, heating, and deaerating of the formulations which were cast as films in the laboratory.
  • a suitable batch size used with the Stephan UMC5 processor was 1500 grams.
  • aqueous starch dispersion was prepared by dissolving any salts/buffers and pH modifiers in deionized water. The starch and/or maltodextrin (M100) were added and mixed until dissolved/dispersed. Pure Cote® B760 and B790 starches are available from the Grain Processing Corporation of Muscatine, Iowa.
  • a hydrocolloid mixture was prepared in the Stephan UMC5 processor by premixing the plasticizers until uniform, and adding the preblended dry hydrocolloids portionwise while mixing for about 30 seconds at 200 rpm after each addition.
  • Sorbitol Special and glycerin were used as plasticizers.
  • Sorbitol Special is an aqueous solution of sorbitol and sorbitol anhydrides at 76% solids supplied by SPI Polyols, Inc. (New Castle, DE).
  • the starch dispersion was added to the non-aqueous hydrocolloid mixture and mixed at 300 rpm for 5 minutes.
  • the mechanical agitation was increased to 2100 rpm and the mixture was heated to 85°C to 95°C with mixing.
  • the target temperature was achieved, the mixture was stirred for 30 minutes, then the sample was held under vacuum (50-60 bars) with continued agitation for an additional 45 minutes.
  • a small portion of the sample was set aside and refrigerated usually overnight prior to measurement of gel/melt properties and solids using an Atago E series hand held refractometer (Gardco, Pompano Beach, FL).
  • the melt temperature was determined by placing a small chunk of the refrigerated gel on a wire string stand held within a test tube so that the chunk does not contact the wall of the test tube.
  • the test tube was covered with aluminum foil with a small hole to allow measurement of the gel temperature using a digital Tempermeter probe.
  • the test tube was immersed in the heating bath so that the chunk is below the surface of a hot water bath at approximately 100 o C.
  • a silicone oil bath was used for samples that had melt temperatures above 90 o C.
  • the melt temperature was recorded when the gelled sample became wet in appearance, softened and could be stirred (a temperature range was noted). Once the sample had melted, the test tube was transferred to a second beaker containing cold tap water (15 o C). The temperature probe was used to record the temperature as the sample was cooled and to probe the sample surface to determine whether the sample had begun to gel. The gel temperature was the temperature upon cooling where the sample no longer flowed to fill in an indentation made by the probe.
  • the hot sample was then cast, using a draw down bar with a gap set at 3mm clearance, onto 177 mm by 177 mm by 5 mm metal plates which were pre-sprayed with PAM (lecithin) to facilitate easy removal of film material.
  • the gel coated plates were covered to avoid loss of moisture from the cast film.
  • Cast films were typically refrigerated (less than 8 o C) for at least one-half hour prior to removal of the film for testing. Refrigeration is not required for film formation.
  • Dried film strips were prepared by drying the coated plates in a 40 °C forced air/fan oven. Films dried 2 hours at 40 o C gave an intermediate solids of about 60%, while films dried overnight at 40 o C typically gave solids of 80% or higher.
  • Test properties were measured at room temperature (approximately 20 °C) unless otherwise specified. The percent of solids of the dried film was determined between the cast film at its formulated solids level and the dried film by difference in weight. Break force (BF) was measured on the cast and dried film strips using a Texture Analyzer TA-108S Mini Film Test Rig.
  • Maltrin M100 was obtained from Grain Processing Corporation, Pure-Cote B760 was obtained from Grain Processing Corporation, Sorbitol Special was obtained from SPI Polyols and Glycerin was obtained from VWR (EP/USP grade).
  • Table 8 shows compositions and film properties for formulations prepared using low viscosity guar ULV 50 in combination with kappa-2 carrageenans.
  • Cgn A is a kappa-2 carrageenan as defined herein that was obtained as an alkali processed, clarified extract of Gigartina skottsbergii , essentially haploid (gametophyte) plants. Minor levels (under 5% total) of lambda- and theta-carrageenans from diploid (tetrasporophyte) plants were also present.
  • Cgn A has a low divalent cation content and low potassium cation content as shown in Table 7.
  • Cgn B is a kappa-2 carrageenan that was obtained as an alkali processed, clarified extract of a mixture of Gigartina skottsbergii and Sarcothalia crispata , primarily haploid (gametophyte) plants. About 10-20% (total) of lambda- and theta-carrageenans from diploid (tetrasporophyte) plants were also present.
  • the properties of the kappa-2 carrageenans are shown in Table 7. Viscosity of an aqueous solution at 1.5 wt % solids was measured at 75 o C using a Brookfield LVF viscometer at appropriate speeds and spindles. The properties of 2% water gels prepared using 2 wt% of samples Cgn A-B (#1) without added cations, (#2) with 0.2 wt% added KCl and (#3) with 0.2% added KCl and 0.2% CaCl 2 , respectively, were characterized using a TXTM Texture Analyzer. Gels were tested at 25 o C and the break force (in grams) and the penetration (in millimeters) was recorded.
  • Example 1-2 demonstrates that a 55 to 45 %by weight mixture of guar with kappa-2 carrageenan has increased strength compared to guar alone (Example 2-1).
  • Example 2-4 demonstrates the desirability of maintaining process temperatures for the molten mass above the gel temperature, as Example 2-5 provided finished (dried) gel strengths, when cast at 95 o C, at least 28% higher than a film cast at 87 o C (Example 2-4).
  • the lower gel strength values are reflective of potential pre-gelation during film formation causing a relatively lower gel strength. All films were free of syneresis upon storage and maintained their relative flexibility.
  • Viscosities were generally found to be at or near the maximum for the test equipment and conditions used. Therefore, use of supplementary equipment with the initial hydration/activation apparatus can provide additional shear and solids concentration effects while maintaining process temperatures well above their high solids set/gel temperatures (> 100 o C.).
  • An example of this supplementary equipment, but not limited to, would be an extruder type device sufficient to maintain adequate temperatures and shear necessary to provide the homogeneous mixing and solids concentrations necessary to allow either shaping of the molten mass for direct film or capsule casting or further allow shaping of the molten mass into a desired form such as a film either for use as a film or further processed into other forms and functions.
  • KCl addition (Example 3-3) increased the gel temperature and also the 40% solids gel strength. Further, KCl addition and varying ratios of film forming ingredients will control cast film strength and gel melt temperatures. When kappa carrageenans are used in combination with low viscosity guar of the invention, control of cation divalency desirably prevents/minimizes gel hardening and brittleness.
  • Table 10 reports the compositions and properties of films formed using low viscosity guar ULV50 with kappa and iota carrageenans.
  • Cgn C is an alkali processed clarified kappa carrageenan extract of Kappaphycus alverezii ( Eucheuma cottonii ).
  • Cgn D is an alkali processed clarified iota carrageenan extract of Eucheuma denticulatum ( Eucheuma spinosum ) with low divalency. Both Cgn C and Cgn D have low divalency.
  • Table 11 presents compositions and properties of films formed using mixtures of guar with potassium alginates and/or carrageenans.
  • Alginates are polyuronate copolymers comprising mannuronate (M) and guluronate(G) units.
  • KAHG is a potassium alginate where the alginate has a high level of G units and is extracted from Laminaria hyperborean .
  • KAHM is a potassium alginate where the alginate has a high level of M units and is extracted from Lessonia nigrescens .
  • Table 12 reports compositions and properties of gel films prepared using blends of low viscosity guar ULV50 with sodium alginates.
  • Protanal® LFR 5/60, Protanal® LF 20/40 and Protanal® SF 120 RB are sodium alginates available from FMC Corporation (Philadelphia, PA).
  • Ex-4-7 Ex 4-8 Ex 4-9
  • Ingredient (g) Water 836.3 836.3 836.3 LFR 5/60 40.5 0 0 LF 20/40 0 40.5 0 SF120 RB 0 0 30 GUAR ULV50 49.5 49.5 45 B760 220.8 220.8 220.8 M100 0 0 15.0 SORBITOL SP 264.4 264.4 264.4 GLYCERIN 88.2 88.2 88.2 Total weight 1500.0 1500.0 1500.0 Temp, ° C.* 90 94 93 VISCOSITY, MPAS* 31,650 >50,000 >50,000 Gel, ° C. 50 NA NA Melt, ° C.
  • Table 13 presents compositions and gel films formed from low viscosity guar ULV 50 in combination with propylene glycol alginate.
  • Protanal® ester BV4830 and Protanal® ester SLF3 are propylene glycol alginates available from FMC BioPolymer (Philadelphia PA).
  • Table 14 lists compositions and properties of gel films prepared using propylene glycol alginate and kappa carrageenan.
  • Protanal® ester BV4830 is a propylene glycol alginates available from FMC Corporation (Philadelphia, PA).
  • HEC is hydroxyethylcellulose.
  • Kappa carrageenan was an alkali processed, clarified extract of Kappaphycus alaverei ( Euchema cottonii ).
  • Table 15 reports compositions and film properties for kappa-2 carrageenan used in combination with propylene glycol alginate and potassium alginate.
  • the kappa-2 carrageenan was an alkali processed, clarified extract of a mixture of Gigartina skottsbergii and Sarcothalia crispata , primarily haploid (gametophyte) plants.
  • potassium cations are supplied by the potassium alginate.
  • the potassium cations promote carrageenan double helix formation at a temperature that allows the carrageenan to form its gel film structure.
  • the additional strength and lower processing viscosity is believed to be due to the higher level of propylene glycol alginate.
  • Cgn A was obtained as an alkali processed, kappa-2 carrageenan clarified extract of Gigartina skottsbergii , essentially haploid (gametophyte) plants and recovered by precipitation with alcohol. Minor levels (under 5% total) of lambda- and theta-carrageenans from diploid (tetrasporophyte) plants were also present.
  • Cgn B was obtained by dissolving Cgn A in water, and recovered by alcohol precipitation and drying. Samples of different molecular weights were obtained by reaction of the dissolved carrageenan with an oxidizing agent to yield Cgn C-F. Sodium hydroxide was added to samples Cgn C-E after the oxidation step and prior to alcohol precipitation to control the pH of the resulting product.
  • the properties of the kappa-2 carrageenans are shown in Table 16. Viscosity of an aqueous solution at 1.5 wt % solids was measured at 75 o C using a Brookfield LVF viscometer at appropriate speeds and spindles. The properties of 2% water gels prepared using 2 wt% of samples Cgn A-F (#1) without added cations, (#2) with 0.2 wt% added KCl and (#3) with 0.2% added KCl and 0.2% CaCl, respectively, were characterized using a TXTM Texture Analyzer. Gels were tested at 25 o C and the break force (in grams) and the penetration (in millimeters) was recorded.
  • Cgn A-F are examples of the kappa-2 carrageenans that can be used in the present invention.
  • Example 6-2 and Example 6-1 the viscosity of the molten mass at processing temperature (13,700 mPas and 4000 mPas, respectively) was controlled by decreasing the molecular weight of Cgn D to CgnE (expressed as viscosity of 24 mPas and 14 mPas, respectively) with an insignificant impact on film properties.
  • Example 6-2, 6-3 and 6-4 The melt temperature of the cast material increased (Examples 6-2, 6-3 and 6-4) as the solids content was increased for a given formulation.
  • the gel temperature increased with increasing solids until the gel temperature approached the temperature of the molten mass.
  • Kappa-2 carrageenan was obtained as an alkali processed, clarified extract of a mixture of Gigartina skottsbergii and Sarcothalia crispata , primarily haploid (gametophyte) plants. About 10-20% (total) of lambda- and theta-carrageenans from diploid (tetrasporophyte) plants was also present. The extract was recovered and subsequently ion exchanged to provide a kappa-2 carrageenan with low divalency. Properties of the low divalent cation kappa-2 carrageenans (Cgn G-J) are shown in Table 18. Cgn G-J are considered to be within the scope of the invention.
  • Ex 7-1 Ex 7-2
  • Ex 7-3 Ex 7-4
  • Ingredients (g) Water 834.7 834.7 834.7 834.7 834.7 Cgn J 75 0 75 75 Cgn I 0 75 0 0 KCl 0 0 9.0 9.0 STARCH B790 0 0 0 227.3 M-100 227.3 227.3 227.3 0 SORBITOL SP 274.9 274.9 274.9 GLYCERIN 91.7 91.7 91.7 91.7 Temp, ° C.* 89 87 87 87 VISCOSITY, MPAS* 5800 5800 6250 10,300 Solids (estimated) 40% 40% 41% 40% Melt, ° C. 45-48 43 66-71 70 Gel, ° C.
  • the ion exchanged kappa-2 carrageenans (I and J) combined with polyols and maltodextrin (as a bulking agent) provided a relatively weaker cast gel film with negligible break force at 40% solids. This is believed to be due to insufficient amounts of potassium cations that are desired to more fully promote carrageenan double helix formation (i.e., gelling) at temperatures that allow the carrageenan to be the primary structuring agent.
  • Examples 7-1 and 7-2 are gel films having relatively lower melt and gel temperatures. Even though gelation potential is not maximized (due to lower potassium levels), Examples 7-1 and 7-2 show a break force of 3468 and 3697, respectively.
  • Example 7-3 demonstrates the effect of potassium ion addition to the structure formed by the kappa-2 carrageenan in Cgn J. Cast strength, although soft, provided sufficient strength for film removal from the casting plate. Structure development by Cgn J, with the addition of potassium ions, is confirmed by the increase in melt and gel temperatures in Example 7-3 as compared to Example 7-1. Break force of the dried film remained comparable to Examples 7-1 and 7-2.
  • Example 7-4 demonstrates the effect of replacing maltodextrin in Example 7-3 by a modified starch (B790). While viscosity was increased, the gel and melt temperatures remained relatively similar to Example 7-3 which contained the maltodextrin.
  • the cast film strength of Example 7-4 was also relatively equal to Example 7-3.
  • the dried film strength of Example 2-4 was more than doubled as compared to Example 7-3. This clearly indicates the structural synergy between the starch and kappa-2 carrageenan, when both are present with potassium cations (i.e., gelling ions for kappa-2 carrageenan). Potassium ions may be provided by direct addition of inorganic salts, organic salts, or combinations thereof or contained within additional ingredients.
  • kappa-2 carrageenan containing residual processing salts can promote the desired gel formation conditions that maximizes gel structure and starch synergy.
  • a homogeneous kappa-2 carrageenan/starch gel structure was formed by casting the molten mass at sufficiently high temperatures to prevent pre-gelation.
  • Example 7-5 was prepared to have equivalent cation content with example 5-1. Both samples show the same gel melt properties.
  • the higher molecular weight of Cgn E (14 cps) in Example 5-1 provided more structural support to the gel film as compared to Cgn H (6 cps) in Example 7-5, as is shown by the higher break force of the dried film.
  • the higher dried film strength of the Example 7-7 shows that use of modified starch in combination with low molecular weight kappa-2 carrageenan provides overall film structure and indicates complexation of kappa-2 carrageenan with the starch.
  • a heated and mixed composition e.g., any of those in Examples 1-7, is formed into a film in a conventional polymer film casting machine by transferring a controlled thickness of the molten composition onto a temperature controlled rotating drum operated at a temperature such that the film formed is suitable for handling and processing in subsequent operations.
  • films Downstream from the film forming operation, films are fed through a series of rollers to counter-rotating dies in a conventional gelatin capsule machine to form, cut and fill capsules of various sizes.
  • two film surfaces are brought into contact under fusing conditions (i.e., time under sufficient local pressure and local temperature to fuse them together).
  • the formed capsules are discharged for further processing. Recovered capsules have sufficient mechanical strength to withstand handling, packaging, and storage conditions.
  • Soft gel capsules (7.5 oval) containing mineral oil (Formula A below) were produced using a Technophar SGM1010 soft capsule machine with 7.25 inch long by 4 inch diameter dies. Preparation of the molten mass used to form the capsule shell was as follows: 11.35 lbs of kappa-2-carrageenan was added to a charge of 33.89 lbs of glycerin in a Ross DS40 jacketed vacuum mixer and dispersed at maximum speed for 5 minutes. An additional 11.35 lbs of kappa-2 carrageenan was added to the mixture and dispersed an additional 5 minutes. A premix of 50 lbs of PureCote B790 modified starch in 94.1 lbs of deionized water was then charged to the mixer.
  • the mixer hood was closed and a 26 inch vacuum was pulled to remove air.
  • the contents were mixed for 30 minutes with the planetary mixer at maximum speed and the disperser at 1/3 maximum speed.
  • the vacuum was locked in and the contents of the mixer were then mixed while heating to 90 o C by applying low pressure steam ( ⁇ 10 psig) to the mixer jacket.
  • the disperser speed was gradually increased to 2/3 maximum while maintaining the molten mass at a temperature of at least 90 o C for 45 minutes.
  • the molten mass was dispensed using a pressurized plate to urge the molten mass to flow as needed from the Ross mixer through a temperature controlled, electrically heated ( ⁇ 125 o C) flexible hose to the covered spreader box.
  • the cast films formed in the spreader box were continuous and even.
  • the films were transported by rollers to the capsule forming dies where capsules were formed, filled with mineral oil and sealed.
  • the capsule sealing temperature was 62 o C and the sealing pressure was ⁇ 2 bars.
  • the ability to seal was improved as the thickness of the ribbon was decreased from 0.28 inches to 0.16 inches.
  • Capsules were tunnel dried for 72 hours at 80 o F and 19% RH.
  • the integrity of the capsule seal remained good after drying.
  • the cast film made from this formulation was dark amber and cloudy with a slight seaweed odor.
  • the break force of the film (0.3 mm in thickness) was 310 g at 58% solids.
  • the breakforce of the film after drying overnight at 40 o C and 40% RH ( ⁇ 80% solids) was 3309 g. See A in Table 21 below.
  • Additional soft capsules (Formula B below) encapsulating mineral oil were produced according to the above process and equipment using a second formulation comprising 39.7 lbs of Sorbitol SP, 59.5 lbs of glycerin, 19.6 lbs of sodium ion exchanged kappa-2 carrageenan, 44.6 Lbs of PureCote B760 starch and 92.6 pounds of water.
  • the Sorbitol SP was added in the starch/water premix.
  • Films produced using this formulation were odorless, transparent and a medium color.
  • the as-cast film had a thickness of 0.6 mm and a break force strength of 263 g at 55% solids.
  • the capsules were evaluated for weight, film thickness for each half of the capsule, and burst strength. Burst strength was measured by compressing the capsule to failure. The compression probe had a speed of 1 mm/sec. Ten capsules were tested for each condition. The shell strength is reported as the capsule burst strength with the seam horizontally positioned. The seam strength was measured for 10 capsules with the seam vertically positioned. Results are shown in Table 21. Both kappa-2-carrageenen films were flexible as indicated by the burst distance and produced a strong capsule seal as indicated by a capsule burst strength that was approximately the same for the capsule shell and the capsule seam and that the capsule did not fail at the seam but at the tip on the seam (away from the point of pressure).

Abstract

Abstract of the Disclosure
The present invention is directed to a process for making homogeneous, thermoreversible gel films comprising the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally, de-aerating a high solids, low moisture film forming composition in an apparatus providing sufficient shear, temperature and residence time to form a homogeneous molten composition, wherein the temperature is at or above the solubilizing temperature of said composition; (ii) feeding the molten composition into at least one of a mixer, pump or devolatilizer; and (iii) cooling the homogeneous molten composition at or below its gelling temperature to form said gel films. The present invention is also directed to various products made from such films, such as the gel films themselves, soft capsules, solid dosage forms and delivery systems.

Description

    Detailed Description of the Invention RELATED APPLICATIONS
  • This application claims the benefit of U.S. Provisional Application Nos. 60/462,785; 60/462,721; 60/462,758; 60/462,617; 60/462,793; 60/462,783; 60/462,792; 60/462,794; all filed on April 14, 2003.
  • FIELD OF THE INVENTION
  • The present invention is directed to a process for making homogeneous, thermoreversible gel films comprising the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally, de-aerating a film forming composition in an apparatus providing sufficient shear, temperature and residence time to form a homogeneous molten composition, wherein the temperature is at or above the solubilizing temperature of said composition; (ii) feeding the molten composition into at least one of a mixer, pump or devolatilizer; and (iii) cooling the homogeneous molten composition at or below its gelling temperature to form said gel films. The present invention is also directed to various products made from such films, such as the gel films themselves, soft capsules, solid dosage forms and delivery systems.
  • BACKGROUND OF THE INVENTION
  • It is known that certain high solids, low moisture film forming compositions containing, for example, hydrocolloids, form highly viscous solutions that make formation of hydrated films difficult to obtain. The present invention provides a process for preparing high solids, low moisture films from such highly viscous solutions.
  • In addition, many attempts have been made to make soft capsules from high solids, low moisture films such as hydrocolloids. However, such attempts to make soft capsules have suffered from the drawback mentioned above. That is, hydrocolloids are known to form highly viscous solutions that are difficult to sufficiently hydrate and form a film in conventional soft capsule making processes. The process of the invention therefore allows for the manufacture of soft capsules from such films.
  • SUMMARY OF THE INVENTION
  • As a first embodiment, the present invention is directed to a process for making homogeneous, thermoreversible gel films comprising the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally, de-aerating a re film forming composition in an apparatus providing sufficient shear, temperature and residence time to form a homogeneous molten composition, wherein the temperature is at or above the solubilizing temperature of said composition; (ii) feeding the molten composition into at least one of a mixer, pump or devolatilizer; and (iii) cooling the homogeneous molten composition at or below its gelling temperature to form said gel films.
  • As a second embodiment, the present invention is directed to the homogeneous, thermoreversible, gel films made from the above process.
  • As a third embodiment, the present invention is directed to a process for making soft capsules comprising the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally, de-aerating a film forming composition in an apparatus providing sufficient shear, temperature and residence time to form a homogeneous molten composition, wherein the temperature is at or above the solubilizing temperature of the composition; (ii) feeding the molten composition into at least one of a mixer, pump or devolatilizer; (iii) cooling the molten composition to or below the solubilizing temperature of the molten composition to form the homogeneous, thermoreversible gel film; and (iii) making soft capsules from the gel film.
  • As a fourth embodiment, the present invention is directed to soft capsules made by the above process.
  • As a fifth embodiment, the present invention is directed to a process for making a solid dosage form comprising a fill material encapsulated by a homogeneous, thermoreversible gel film comprising the steps of: (i) preparing the homogeneous, thermoreversible gel film in accordance with the above process; and (ii) encapsulating the fill material in the gel film. The present invention is also directed to solid dosage forms made from the process.
  • As a sixth embodiment, the present invention is directed to a process for preparing a homogeneous gel film delivery system comprising an active substance and a homogeneous, thermoreversible gel film, comprising the steps of: (i) preparing the molten composition in the above process; (ii) adding an effective amount of an active substance prior to or after formation of the molten composition: and (iii) cooling the molten composition containing the active substance at or below its gelling temperature to form the gel films containing the active substance. The present invention is also directed to delivery systems made by the process.
  • As a seventh embodiment, the present invention is directed to a process for making homogeneous, thermoreversible gel films comprising the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally de-aerating a film forming composition in an apparatus providing sufficient shear, temperature and residence time to form a homogeneous molten composition, wherein the temperature is at or above the solubilizing temperature of the composition; and (ii) cooling the homogeneous molten composition at or below its gelling temperature to form said gel films. The present invention is also directed to dosage forms, solid forms and delivery systems made by the process.
  • DESCRIPTION OF THE FIGURES
  • Figure 1 is schematic of a process of the present invention to make films and soft capsules using a Stephan processor together with an extruder. The extruder is optional in this figure, and the Stephan processor can be replaced with, e.g., a Ross mixer. Further, while this figure refers to "LV Guar" (low viscosity guar), this invention is not limited thereby.
  • Figure 2 is a schematic of a process of the present invention to make films and soft capsules using a fluid mixing apparatus such as in Figure 3 together with an extruder. The extruder is optional in this figure.
  • Figure 3 is a partially broken away, side elevational view of the fluid mixing apparatus for mixing first and second fluids with steam that can be used in the process of Figure 2.
  • Figure 4 is another version of the schematic of Figure 2 showing the film coming out of the extruder proceeding to an encapsulation apparatus.
  • DETAILED DESCRIPTION OF THE INVENTION
  • A first embodiment of the present invention is a process for making homogeneous, thermoreversible gel films comprising the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally, de-aerating a film forming composition in an apparatus capable of providing sufficient shear, temperature and residence time to form a molten composition, wherein the temperature of the molten mass is maintained at or above its solubilizing temperature; (ii) feeding said molten composition into at least one of a mixer, pump or devolatilizer; and (iii) cooling said molten composition at or below is gelling temperature to form said gel films.
  • The process of the present invention provides homogeneous, thermoreversible gel films having, e.g., a relatively high solids content.
  • As used herein, "homogeneous film" defines films that, to the naked eye, are visually uniform and free of defects such as lumps, cracks, particles that are undissolved that should be dissolved, non-uniform distribution of insoluble particles, etc. "Fish eyes" (mixed liquid and solid states) or "gel balls" (non-uniform gel structure) would not meet the definition of "homogeneous" as used herein.
  • The gel films of the present invention are homogeneous, thermoreversible gel films. They can be cast and used in a variety of applications as cast films or in further processing.
  • As used herein, "thermoreversible film" defines a film that has a melting temperature. As used herein, the melting temperature is the temperature or temperature range over which the gel film softens or flows.
  • As used herein, the phrase "gel films" refer to a thin membrane formed from, e.g., structured hydrocolloid. The gel-forming composition is characterized by a gel temperature, the temperature below which the molten mass of the gel composition must be cooled to form a self-supporting structure. Optionally, a molten mass can be cast hot and allowed to cool, as well as dry to further concentrate the solids (controlled moisture removal) until a gel film is formed by the gel composition. The melt temperature of a thermoreversible gel film is higher than its gel temperature.
  • As used herein, the "solubilizing temperature" means the temperature at which the composition becomes homogeneous. Solubilizing refers to the act of fully dissolving all the soluble components in the molten composition and all insoluble materials are uniformly dispersed.
  • The components in the film forming system can be any components found in film forming compositions that form high solids, low moisture gel films when heated and hydrated and that form homogeneous, thermoreversible gel films. For example, such compositions can contain thermoreversible hydrocolloids.
  • The thermoreversible hydrocolloids that can be used in the present invention to form thermoreversible gel films include polysaccharides such as: carrageenan including iota carrageenan, kappa carrageenan, kappa-2 carrageenan; xanthan gum; polymannan gums (e.g., glucomannan gums and galactomannan gums) such as locust bean gum, konjac, tara gum, cassia gum, guar gum (e.g. low viscosity guar gum); alginates including propylene glycol alginate and monovalent salts of alginates such as potassium and sodium; pullulan; gellan (including high and low-acyl gellan); dextran; pectin and combinations thereof. The carrageenans can be modified, less than fully modified or unmodified. As used herein, kappa-2 carrageenan has a molar ratio of 3:6-anhydrogalactose-2-sulfate (3:6-AG-2-S) to 3:6-anhydroglactose (3:6-AG) content of 25 to 50%, iota carrageenan has a molar ratio of 3:6AG-2S to 3:6AG content of 80 to 100% and kappa carrageenan has a molar ratio of 3:6AG-2S to 3:6AG content less than that for kappa-2 carrageenan. For example, kappa carrageenan from Eucheuma cottonii , a commonly known and used seaweed source for kappa carrageenan, has a molar ratio of 3:6AG2-S to 3:6AG content of less than about 10%; and iota carrageenan from Spinosum , a commonly known and used seaweed source for iota carrageenan, has a molar ratio of 3:6AG2-S to 3:6AG content greater than about 85%. This means that kappa-2 carrageenan comprises a ratio of kappa (3:6-AG) repeating units to iota (3:6-AG-2-S) repeating units between 1.0 to 3.0:1, more particularly, 1.5 to 3.0:1 (more particularly depending on the desired application). The molar ratio of 3:6AG-2S to 3:6AG content in these carrageenans holds regardless of its degree of modification and precursor content (e.g, mu and nu repeating units).
  • The homogeneous, thermoreversible gel film made by the process of the present invention can optionally contain at least one of a plasticizer, a second film former, a bulking agent and a pH controlling agent depending on their application.
  • Examples of such a plasticizer include polyols such as glycerin, sorbitol, maltitol, lactitol, corn starch, fructose, polydextrose, solubilized oils and polyalkylene glycols such as propylene glycol and polyethylene glycol. For example, such plasticizers can generally be used in an amount of at least 5%, more preferably, at least 10%, more preferably, at least 20%, more preferably, at least 30% by weight of all the components including water in the dry film if a gel film having more elasticity is desired; e.g., films to be used to make soft capsules. For other applications, such as hard capsules, where less elastic films are desired, the plasticizer can be present in an amount of 0% to 20% by weight of all the components in the dry film. It is possible that the gel film of the invention contains no plasticizer at all. If desired, where iota, kappa or kappa-2 carrageenan is used as the hydrocolloid, such carrageenan can have a viscosity of 19 cps or less, more particularly less than 10 cps, at 75 °C when measured 0.10 molar sodium chloride solution containing 1.5% of such carrageenan by weight based on the total weight of the composition. This viscosity test can be performed using a Brookfield LVF (Brookfield Engineering Laboratories, Inc.) viscometer using Spindle #1 at 60 r.p.m. and determining the viscosity after six revolutions.
  • Examples of the second film former that can be used in the present invention include at least one of a starch, starch derivative, starch hydrozylate, cellulose gum, hydrocolloid, an alkylcellulose ether or a modified alkyl cellulose ether. Examples of the hydrocolloids are those listed above. Others include non-gelling carrageenans such as lambda carrageenan. An example of an alkylcellulose ether that can be used in the present invention is hydroxyethylcellulose. Examples of modified alkylcellulose ethers that can be used in the present invention include hydroxypropylcellulose and hydroxypropylmethylcellulose. The primary film former can be the only film former in the gel film. When the gel films of the present invention contain second film formers, the primary film former can be present in an amount of at least 10%, at least 40%, at least 60% or at least 80% by weight of the total amount of film formers in the gel film.
  • Examples of the bulking agent include microcrystalline cellulose, microcrystalline starch, modified and unmodified starch, starch derivatives, inulin, starch hydrozylates, sugar, corn syrup and polydextrose. As used herein and in the claims, the term "modified starch" includes such starches as hydroxypropylated starches, acid-thinned starches, and the like. Examples of modified starches that can be used in the present invention include Pure Cote? B760, B790, B793, B795, M250 and M180, Pure-Dent? B890 and Pure-Set? B965, all available from Grain Processing Corporation of Muscatine, Iowa, and C AraTex? 75701, available from Cerestar, Inc. Examples of starch hydrozylates include maltodextrin also known as dextrin. Unmodified starches such as potato starch can also contribute to the film strength when combined with the hydrocolloids within the scope of the invention. In general, modified starches are products prepared by the chemical treatment of starches, for example, acid treatment starches, enzyme treatment starches, oxidized starches, cross-bonding starches, and other starch derivatives. It is preferred that the modified starches be derivatized wherein side chains are modified with hydrophilic or hydrophobic groups to thereby form a more complicated structure with a strong interaction between side chains.
  • The amount of the bulking agent to be used in the present invention is generally in the amount of 0 to 20% by weight of the dry film, but more can be used, if desired, for example, at least 20%, more preferably, at least 30% of the dry film depending on the application.
  • Note that starch, starch derivatives and starch hydrozylates can be multifunctional. That is, in addition to being used as bulking agents, they can be used as second film formers. When such are used as bulking agents and second film formers, they are generally used in an amount of at least 10%, preferably, at least 20%, by weight of the gel film.
  • Examples of the pH controlling agent to be used in the present invention include bases such as hydroxides, carbonates, citrates and phosphates. The pH controlling agent can be chosen as the source of added beneficial cations such as potassium. For some compositions, the pH controlling agent can be used to improve the stability of the gel film. The amount of the pH controlling agent is generally in the amount of 0 to 4%, preferably, 0 to 2%.
  • The dry films made from the gels of the present invention have been found to have, for example, a break force of at least at least 1,000 grams, at least 2,500 grams, at least 4,000 grams, at least 5,000 grams, at least 6,000 grams, as determined by using a Texture Analyzer TA-108S Mini Film Test Rig. In some cases, wet films made by the process of the present invention have yielded low break force strength (e.g., 250-320g), but have produced strong dried films having the break force strengths mentioned above.
  • The gel films of the present invention have been found to have a solids content of at least 50%, at least 60%, at least 70%, at least 80% and at least 90% of all components in the gel film. It is understood that up to 15%, 10%, 5% water may remain strongly associated with the solids in the gel film.
  • Dry film thicknesses generally used for soft capsules are in the range of 0.5 to 3.0mm, more preferably, 0.8 to 1.2 mm.
  • It is possible that the films of the present invention can contain nonthermoreversible gums. However, so as not to adversely impact the homogeneous and thermoreversible nature of the gel films of the present invention, such nonthermoreversible gums should be present in an amount of less than 50% by weight of the thermoreversible film former, preferably, less than 40% more preferably, less than 30%. Examples of such nonthermoreversible gums include crosslinked or partially crosslinked gums such as calcium set (e.g., crosslinked) pectins or alginates. Calcium reactive alginates and pectins, as well as their less refined forms, are considered as thermoreversible gums in the absence of divalent cations.
  • The gel films of the present invention are generally made from a process utilizing an apparatus that enables sufficiently high shear, temperature (above the gelling temperature) and residence time so as to provide a homogeneous molten mass of the composition and formation of the gel upon cooling. This is generally accomplished in the apparatus by heating, hydrating, mixing, solubilizing and optionally de-aerating the composition. Such apparatus include but are not limited to Ross mixers, Stephan processors, conventional jet cookers, extruders and the fluid mixing apparatus as set forth in Figure 3. Ross mixers, Stephan processors, extruders and conventional jet cookers are readily available commercially. Prior to cooling, the molten mass can be fed to at least one of a pump, mixer or devolatilizer. An example of a device that performs any one of such functions is an extruder. An extruded molten mass can also be directed to a film forming or shaping device (e.g. spreader box, as used in a capsule forming machine) that aids in the uniform casting of a continuous film, or, through a die that allows a direct formation of a film from the molten mass delivery equipment. Care must be taken to maintain the molten mass above the initiation of restricted flow/gel structure formation. Insulated and pre-heated (to maintain proper temperatures) transfer hoses may be used to insure molten mass flow until desired gel film formation is initiated on the casting rolls or at other film formation points, such as an extruder (restrictive flow, film forming device) or die. Additional processing methods (such as pre-heating the discharge/plunger-like head as seen in a Ross process system) can force (by pressure) the molten mass through the transfer hoses mentioned above. Additional insulation can help maintain molten mass temperatures through the use of a Teflon disk initially placed upon the molten mass surface immediately after removing the mixing device. In addition, the feeder hoses can be introduced to the heat controlled molten mass feeder (casting) boxes located on a capsule machine either directly to the boxes or through an optional modification of the feeder boxes which introduces a top half enclosure/cover that helps maintain molten mass temperatures within the feeder box, reduces moisture loss, and maintains uniform (center) filling of the box during the extended process of forming films for capsules. It is understood that other methods of maintaining molten mass temperatures can be used to form films for capsules. This includes, but is not limited to extrusion of the molten mass through dies/orifices into films that: can be immediately fed into the capsule forming apparatus, stored at temperatures that maintain proper film conditions (to form capsules) until needed, or dried to desired moisture, solids and texture levels, until needed. Such dried films have the property of re-absorbing water (water is introduced by any means) throughout its gel film matrix and can be rehydrated when needed, for example, to make soft capsules or other solid forms. Moisture is introduced to the film until a desired moisture content and strength/texture is reached that will allow the film's introduction into a capsule machine to make soft capsules.
  • When a Stephan processor or conventional jet cooker is used, a typical process for using such with hydrocolloids is as follows. The components of the film forming composition are fed into the Stephan processor and heated (while agitating) to a temperature, which provides solubility to the components above their gel temperature. The material can then be processed into a gel film or as a molten mass. Further processing can be completed on this material while utilizing appropriate equipment to allow it to develop its final form.
  • As used herein, a "fluid mixing apparatus" refers to the apparatus in FIG. 3. FIG. 3 illustrates a fluid mixing apparatus 10 . The fluid mixing apparatus 10 is arranged to mix steam 2 with a first fluid or slurry 4 and a second fluid or slurry 6 to produce a molten mass or slurry mixture 8 .
  • The fluid mixing apparatus 10 comprises a first housing 20 having a first inlet 22 through which the steam 2 enters the housing 22 , a nozzle end 24 from which the steam 2 exits the housing 20 , and a nozzle valve or stem 26 disposed at the nozzle end 24 . An actuator means 30 is connected to the first housing 20 for controlling the exit rate or exit pressure of the first fluid 2 at the nozzle end 24 . The actuator means 30 may be of the type manufactured by Fisher Controls U.S.A.
  • The fluid mixing apparatus 10 further comprises a second, mixing housing 40 coupled to the first housing 20 at the nozzle end 24 of the first housing 20 . The second housing 40 includes a second inlet 42 through which the first fluid 4 enters the second housing 40 , and a third inlet 44 through which the second fluid 6 enters the second housing 40 . The inlets 42 and 44 are disposed downstream of the first inlet 22 . As shown in FIG. 3, the second inlet 42 and third inlet 44 are disposed in a common plane and spaced apart radially from each other, most preferably directly opposite (i.e., 180º apart) about the central axis Y of the mixing apparatus 10 . The second housing 40 defines a generally cylindrical mixing chamber 52 that in turn defines a flow passage extending along the axial length of the mixing chamber 52 from an entry end 54 of the mixing chamber 52 to an exit end 56 of the chamber 52 . The nozzle valve 26 is movable by the actuator 30 between seated and unseated positions at the entry end 54 to control the flow rate of steam 2 into the mixing chamber 52 .
  • The nozzle end 24 of the first housing 20 directs the steam 2 into the entry end 54 of the mixing chamber 52 . The second inlet 42 and the third inlet 44 radially direct the first fluid 4 and second fluid 6 , respectively, into the mixing chamber 52 . The steam 2 , first fluid 4 and second fluid 6 are mixed in the mixing chamber 52 to form a molten mass or mixture 8 which exits the mixing chamber 52 . The molten mass 8 then may be shaped into a shaped article or formed into a film, such as by casting the mixture 8 onto a cooling drum or by passing the mixture 8 through an extruder.
  • Once the molten mass composition is prepared and such is maintained at a temperature at or above the solubilizing temperature, the molten mass may be then fed directly into at least one of a pump, mixer or devolatilizer. Then, the molten mass is cooled down to or below the gelling temperature of the composition to form the gel film.
  • It is preferred that the solubilizing temperature be greater than the boiling point of the homogeneous molten composition at atmospheric pressure and that the heating, hydrating, mixing and solubilizing is conducted above atmospheric pressure.
  • A preferred process comprises feeding the molten composition directly into a mixer, deareated, depressurized and pumped prior to cooling to or below the molten composition's gelling temperature.
  • One device that contains at least one of a pump, mixer and devolatilizer is an extruder. An extruder is preferred device for devolatilizing and thereby concentrating the solids of the molten composition prior to cooling.
  • Extruders that can be used in the present invention include single or dual barrel extruders with inlet devices sufficient to allow transfer of the fully or partially hydrated composition without incurring a temperature drop during the transfer. Once the compositional material achieves its targeted solids content and the temperature is maintained above its gel temperature, the resulting molten mass can be used as previously described.
  • As another aspect of the invention, it is noted that the molten mass need not necessarily reach homogeneity in step (i). That is, homogeneity of the molten mass can be obtained prior to or after feeding the molten composition into at least one of the mixer, pump or devolatilizer provided the molten mass reaches homogeneity prior to gelling.
  • Since the gel films of the present invention have been shown to have dry film strengths, e.g., of at least 2,500 grams, they are well suited for a variety of applications. For example, such gel films can be used to make soft capsules. Thus, as a second embodiment, the present invention is a process for making soft capsules comprising the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally, de-aerating the film forming composition in the apparatus capable of providing sufficient shear, temperature and residence time to form a molten composition, wherein the temperature is at or above the solubilizing temperature of the molten mass; (ii) feeding the molten composition into an extruder to form a high solids, low moisture, homogeneous, thermoreversible gel film; and (iii) making soft capsules from the gel film. The gel film and its components, as well as the apparatus and extruder that can be used, are as set forth above.
  • The process for making soft capsules of the invention includes the use of any conventional encapsulating apparatus once the gel films discussed are prepared, e.g., a conventional rotary die apparatus or concave stamping die. For example, once the molten mass of the present invention has been made, it can be cast onto drums, cooled and then fed between rotary encapsulation dies where the films are heated again, filled, sealed and cut. For a good description of this conventional process, see WO 98/42294. Alternatively, and as a benefit of the present invention over conventional soft capsule processes, the use of the high shear apparatus disclosed above allows the molten mass to be sufficiently hydrated, extruded, applied to drums as they are cooling and then fed into conventional encapsulating apparatus for filling, sealing and cutting. This continuous type process can be used to eliminate the step of having to reheat fully gelled and cooled films for capsule preparation.
  • Other applications of the gel films of the present invention include process for making a solid form comprising a fill material encapsulated by the homogeneous, thermoreversible gel film of the present invention. One type of such solid form is a hard capsule. Hard capsules, as used herein, refer to those solid forms that are conventionally used, e.g., in the pharmaceutical industry whereby two half shells are formed, a fill material, usually a powder, is placed in the shells and the two halves are placed together to form the hard capsule. The process for making such hard capsules would typically involve dipping metal pins or bars into the molten composition of the present invention and allowing the gel film to form around the pins. The gel films are dried and then removed from the pins. These processes are well known in the industry as methods of making hard capsules. The fill materials for the hard capsules can be any fill materials commonly used in such dosage forms. Generally, the fill materials can be liquids or solids such as powders. The fill materials can be a pharmaceutical ingredient, agricultural ingredient, nutraceutical ingredient, veterinary ingredient, food, cosmetic ingredient, flavorant, etc.
  • The solid form may also encapsulate a powder, tablet, caplet, microcapsule or capsule in accordance with known techniques. For example, encapsulating a hard capsule with the gel film of the invention would allow for safety seal/tamper resistant capabilities.
  • The gel film can also be used to modify the dissolution profile of the dosage forms. For example, gel films of the invention can contain added components that can create solid dosage forms having immediate release, controlled, enteric or delayed release capabilities. Definitions of "immediate release", "delayed release" and "enteric" can be found in the U.S. Pharmacopeia and are incorporated herein by reference.
  • In addition, the gel films of the present invention can be used in a process for preparing a homogeneous gel film delivery system comprising an active substance and a homogeneous, thermoreversible gel film, comprising the steps of: (i) preparing the molten composition; (ii) adding an effective amount of an active substance thereto; and (iii) cooling said molten composition containing said active substance at or below its gelling temperature to form said gel films containing said active substance. The active substance can include at least one of an oral care agent, a breath freshening agent, a pharmaceutical agent, a nutraceutical agent, a salivary stimulant agent, a vitamin, a mineral, a coloring agent, a sweetener, a flavorant, a fragrance, a food.
  • Process for making homogeneous, thermoreversible gel films of the present invention also comprises the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally, de-aerating a film forming composition in an apparatus providing sufficient shear, temperature and residence time to form a homogeneous molten composition, wherein the temperature is at or above the solubilizing temperature of the composition; and (ii) cooling the homogeneous molten composition at or below its gelling temperature to form said gel films. This process can be used to make dosage forms, solid forms and delivery systems as mentioned above. An apparatus especially suited for this process is the Ross mixer and, when making soft or hard capsules, can be used to provide the gel film directly to the capsule making machine or, if desired, to rollers for use at a later time. All of the materials described herein can be used in this process.
  • The present invention is now described in more detail by reference to the following examples, but it should be understood that the invention is not construed as being limited thereto. Unless otherwise indicated herein, all parts, percents, ratios and the like are by weight.
  • EXAMPLES
  • Example 1
  • The following example uses the fluid mixing apparatus of FIG. 3 to make the gel films of the present invention. In this example, Parts A and Parts B were pumped from separate holding tanks at ambient temperature, as two separate streams 4, 6, into two different inlet ports 42, 44 which fed the steam injection fluid mixing apparatus device 10. The two individual streams 4, 6 were combined at the interface of the steam in the mixing zone 52 of the fluid mixing apparatus 10. The separate solutions of Part A and Part B were readily pumped into the fluid mixing apparatus 10 and mixed with steam 2. The steam 2 was introduced to the mixing zone at a pressure of 120 psi. The resulting molten mass or slurry mixture 8 flowed out of the exit port 56 of the fluid mixing apparatus 10. The mixture 8 was poured onto a smooth surface and drawn down to form a homogeneous film 9.
  • To measure the viscosity of the mixture 8, approximately 500 ml sample of the mixture 8 was collected from the outlet 56 and poured into a jar. The temperature, pH and viscosity were measured for this sample at 95ºC. A Brookfield LVF viscometer was used to measure the viscosity. An appropriate speed and spindle combination were used such that a reading could be taken. The dial reading was converted to dynamic viscosity (cP).
  • To measure the film strength and solids level, the molten mass 8 was collected from the outlet 56 then cast using a draw down bar, with a gap set at 3 mm, onto a stainless steel metal plate. The initial films 9 or "fresh films" were collected. Portions of the fresh films 9 were dried by placing them in a 40ºC forced air oven. Break force was measured on the cast and dried film strips using a Texture Analyzer TA-108S Mini Film Test Rig. The percent solids were determined by measuring the difference between the initial weight of the fresh film and the final weight of the dried films.
  • To measure the gel temperature, a portion of the molten mass 8 was collected from the outlet 56 of the mixing apparatus 10 and transferred to a test tube. Half of the test tube remained empty. A glass thermometer was inserted into the molten mass 8. The material 8 was allowed to cool under room temperature conditions. After each degree of cooling, the thermometer was removed from the material 8. When a small, temporary indentation was observed in the surface of the mass 8, this temperature was recorded. The thermometer was re-inserted into the mass 8, which was allowed to cool further. The thermometer was removed and re-inserted at every degree of cooling until such a time as a permanent indentation formed in the mass 8, such that the indentation did not refill. The temperature at which the permanent indentation formed was recorded. The gel temperature reported was the range between the two recorded temperatures. The components in the Tables below are further defined below in Tables 5 and 6.
  • Table 1 - Mixtures Containing Carrageenan
  • Example No. 1A 1B 1C 1D 1E
    Part A (%)
    Carrageenan D 0.0 0.0 0.0 0.0 8.9
    Carrageenan C 7.0 8.4 8.9 0.0 0.0
    Carrageenan B 0.0 0.0 0.0 8.9 0.0
    Glycerin 26.5 31.8 33.5 33.5 33.5
    Part B (%)
    Starch 16.4 19.7 20.7 20.7 20.7
    Water 50.0 40.0 36.9 36.9 36.9
    Mixing chamber 107 107 108 108 108
    temp. (° C.)
    Outlet temp (° C.) 101 102 102 102 102
    Viscosity cP (@ 7300 5200 48000 50000 12400
    95° C.)
    pH 7.3 Not tested 8 6.4 6.7
    % solids 53 54 65 61 53
    Gel temp. (° C.) 46-50 43-47 53-60 80-85 49-52
    wet film strength 267 214 983 2693 975
    (grams)
    dry film strength 2958 6798 4594 6457 7017
    (grams)
    Avg film thickness 1.3 (74%)
    (mm) (% solids) 1.7 (59%)
  • Table 2 - Mixtures Containing Propylene Glycol Alginate
  • Example No. 2A 2B 2C 2D 2E
    Part A (%)
    Carrageenan C 2.7 3.2 3.2 4.0 0.0
    Carrageenan B 0.0 0.0 0.0 0.0 4.0
    PGA 3.3 3.9 3.9 4.9 4.9
    Glycerin 22.4 26.5 26.5 33.5 33.5
    Part B (%)
    KOH 0.0 0.0 0.1 0.0 0.0
    K 2 CO 3 0.0 0.0 0.0 0.3 0.3
    Starch 13.9 16.4 16.4 20.7 20.7
    Water 57.8 50.0 49.9 36.6 36.6
    Mixing chamber 108 107 108 107 108
    temp. (° C.)
    Outlet temp (° C.) 102 102 102 101 102
    Viscosity cP (@ 5500 4650 2200 12400 9400
    95° C.)
    pH 4.1 4.2 8.7 6.3 6.8
    % solids 48 50 not tested 58 57
    Gel temp. (° C.) 35-40 not tested not tested 58-66 63-71
    wet film strength 60 117 not tested 337 822
    (grams)
    dry film strength 2408 3069 4335 4561 4795
    (grams)
    Avg film thickness 1.2
    (mm) (% solids) (91%)
    1.1
    (57%)
  • Table 2 shows that the film former can be a combination of hydrocolloids, such as carrageenan and PGA. Additionally, salts can be added to influence film properties such as strength, gel temperature and pH.
  • Table 3 - Mixtures Containing Low Viscosity Guar
  • Example No. 3A 3B 3C
    Part A (%)
    Carrageenan E 0 4.0 4.2
    Carrageenan B 4.3 0.0 0.0
    ULV guar 4.6 4.9 5.1
    Glycerin 33.5 33.5 27.0
    Sorbitol 0.0 0.0 8.1
    Part B (%)
    Starch 20.7 20.7 21.8
    Water
    Mixing chamber temp. (° C.) 108 108 108
    Outlet temp (° C.) 102 102 102
    Viscosity cP (@ 95° C.) 7900 7800 69000
    pH 6.5 5.6 5.5
    % solids 57 57 55
    Gel temp. (° C.) 60-65 >100 >100
    wet film strength (grams) 460 3402 921
    dry film strength (grams) 5299 6587 9234
  • Table 3 shows that the film former can be a combination of hydrocolloids such as carrageenan and guar.
  • Table 4 - Mixtures Containing PES
  • Example No. 4A 4B
    Part A (%)
    Carragennan G 0.0 8.9
    Carrageenan F 8.9 0.0
    Glycerin 33.5 33.5
    Part B (%)
    Starch B790 20.7 20.7
    Water 36.9 36.9
    Mixing chamber temp. ° C.) 108 108
    Outlet temp (° C.) 102 102
    Viscosity cP (@ 95° C.) >100K 8400
    PH 7.5 8
    % solids 46 49
    Gel temp. (° C.) >100 >100
    wet film strength (grams) 722 360
    dry film strength (grams) 1095 4213
  • Table 4 illustrates that PES and upgraded PES can be processed in the mixing apparatus 10. The upgraded PES provides some advantages, such as a lower outlet viscosity, and results in a higher strength dry film. The following Tables 5 and 6 provide further descriptions of the components specified in this Example.
  • Table 5 - Component Descriptions
  • Name Trade Name Supplier Description
    Gelatin Kind and Knox 150 Bloom, Type
    B
    Propylene gly- Pronatal BV 4830 FMC Corporation
    col algin-
    ate (PGA)
    low viscosity Edicol ULV 50 Indian Gum
    guar (LV guar) Industries, Ltd.
    Glycerin Callahan Chemi- 99.70%
    cal
    Sorbitol Sorbo SPI Polyols 70% sorbitol sol-
    ution, USP/FCC
    Starch Pure-Cote B790 Grain Processing
    Corporation
  • Table 6 - Carrageenan Descriptions
  • Carrageenan
    Reference Type Description Supplier
    Carrageenan Iota An alkali processed, clari- FMC
    A fied iota-carrageenan ex- Corporation
    tract of Eucheuma denti-
    culatum ( Eucheuma spin-
    osum) with low divalency
    Carrageenan Kappa An alkali processed, clari- FMC
    B fied kappa-carrageenan Corporation
    extract of Kappaphycus
    alverezii ( Eucheuma
    cottonii) with low divalency
    Carrageenan Kappa-2 An alkali processed, clari- FMC
    C fied, low divalency ex- Corporation
    tract of a mixture of Gigar-
    tina skottsbergii and
    Sarcothialia crispata,
    primarily haploid (gameto-
    phyte) plants, such ex-
    tract being commonly
    known as “kappa-2
    carrageenan”. Includes
    about 10-20% (total) of
    lambda and theta-carra-
    geenans from diploid (tetra-
    sporophyte) plants.
    Defined as the natural ran-
    dom block copolymer of
    kappa- and iota- in the
    ratio of about 1.0 to 3.0:1
    respectively, and has sig-
    nificantly different func-
    tionalities compared to mix-
    ing individual kappa and
    iota-carrageenan natural
    polymers at the same
    ratio.
    Carrageenan Very low An alkali processed, clari- FMC
    D divalent Kappa fied kappa-carrageenan ex- Corporation
    tract of Kappaphycus
    alverezii ( Eucheuma
    cottonii) converted to the
    pure sodium salt with dival-
    ent cations removed.
    Carrageenan Low divalent An alkali processed, clari- FMC
    E Kappa-2 fied, low divalency extract
    of Gigartina skotts-
    bergii, essentially hap-
    loid (gameophyte) plants,
    such extract being comm-
    only known as “kappa-2
    carrageenan”. Also includes
    minor levels (under 5% tot-
    al) of lambda- and theta-
    carrageenans from diploid
    (tetrasporophyte) plants.
    Defined as the natural
    random block copolymer
    of kappa- and iota-carra-
    geenans in the ratio of
    about 1.0 to 3.0:1 respect-
    ively, and has significantly
    different functionalities
    compared to mixing indiv-
    idual kappa- and iota-carra-
    geenan natural polymers at
    the same ratio.
    Carrageenan PES Kappa An alkali processed, non- FMC
    F clarified, processed Corporation
    Eucheuma seaweed product
    (containing kappa-carra-
    geenan) of Kappaphycus al-
    verezii( Eucheuma
    cottonii) with low di-
    valency.
    Carrageenan upgraded An alkali processed, non- FMC
    G PES Kappa clarified, pre-gelatinized Corporation
    kappa-carrageenan extract
    of Kappaphycus alverezii
    (Eucheuma cotonii) with
    low divalency, prepared as
    per example 5 in U.S. Pat.
    No. 6,479,649
  • As described and demonstrated above, the films made in accordance with this invention can be used in conventional capsule making equipment previously used for making gelatin capsules.
  • Procedures for Examples 2-7
  • Unless otherwise indicated, the following procedures were used to prepare and evaluate the materials and films in Examples 2-7. The Stephan UMC5 processor is a laboratory scale-mixing device which provided suitable high shear mixing, heating, and deaerating of the formulations which were cast as films in the laboratory. A suitable batch size used with the Stephan UMC5 processor was 1500 grams.
  • An aqueous starch dispersion was prepared by dissolving any salts/buffers and pH modifiers in deionized water. The starch and/or maltodextrin (M100) were added and mixed until dissolved/dispersed. Pure Cote® B760 and B790 starches are available from the Grain Processing Corporation of Muscatine, Iowa.
  • A hydrocolloid mixture was prepared in the Stephan UMC5 processor by premixing the plasticizers until uniform, and adding the preblended dry hydrocolloids portionwise while mixing for about 30 seconds at 200 rpm after each addition. Sorbitol Special and glycerin were used as plasticizers. Sorbitol Special is an aqueous solution of sorbitol and sorbitol anhydrides at 76% solids supplied by SPI Polyols, Inc. (New Castle, DE).
  • The starch dispersion was added to the non-aqueous hydrocolloid mixture and mixed at 300 rpm for 5 minutes. The mechanical agitation was increased to 2100 rpm and the mixture was heated to 85°C to 95°C with mixing. When the target temperature was achieved, the mixture was stirred for 30 minutes, then the sample was held under vacuum (50-60 bars) with continued agitation for an additional 45 minutes.
  • When the hold time under vacuum at temperature has been completed, the sample was poured into a preheated wide mouth quart Mason jar. Temperature and pH were recorded. Viscosity was measured on the hot sample using a Brookfield LVF viscometer.
  • A small portion of the sample was set aside and refrigerated usually overnight prior to measurement of gel/melt properties and solids using an Atago E series hand held refractometer (Gardco, Pompano Beach, FL). The melt temperature was determined by placing a small chunk of the refrigerated gel on a wire string stand held within a test tube so that the chunk does not contact the wall of the test tube. The test tube was covered with aluminum foil with a small hole to allow measurement of the gel temperature using a digital Tempermeter probe. The test tube was immersed in the heating bath so that the chunk is below the surface of a hot water bath at approximately 100 o C. A silicone oil bath was used for samples that had melt temperatures above 90 o C. The melt temperature was recorded when the gelled sample became wet in appearance, softened and could be stirred (a temperature range was noted). Once the sample had melted, the test tube was transferred to a second beaker containing cold tap water (15 o C). The temperature probe was used to record the temperature as the sample was cooled and to probe the sample surface to determine whether the sample had begun to gel. The gel temperature was the temperature upon cooling where the sample no longer flowed to fill in an indentation made by the probe.
  • The hot sample was then cast, using a draw down bar with a gap set at 3mm clearance, onto 177 mm by 177 mm by 5 mm metal plates which were pre-sprayed with PAM (lecithin) to facilitate easy removal of film material. The gel coated plates were covered to avoid loss of moisture from the cast film. Cast films were typically refrigerated (less than 8 o C) for at least one-half hour prior to removal of the film for testing. Refrigeration is not required for film formation. Dried film strips were prepared by drying the coated plates in a 40 °C forced air/fan oven. Films dried 2 hours at 40 o C gave an intermediate solids of about 60%, while films dried overnight at 40 o C typically gave solids of 80% or higher. Test properties were measured at room temperature (approximately 20 °C) unless otherwise specified. The percent of solids of the dried film was determined between the cast film at its formulated solids level and the dried film by difference in weight. Break force (BF) was measured on the cast and dried film strips using a Texture Analyzer TA-108S Mini Film Test Rig.
  • Unless otherwise indicated, Maltrin M100 was obtained from Grain Processing Corporation, Pure-Cote B760 was obtained from Grain Processing Corporation, Sorbitol Special was obtained from SPI Polyols and Glycerin was obtained from VWR (EP/USP grade).
  • Example 2
  • Table 8 below shows compositions and film properties for formulations prepared using low viscosity guar ULV 50 in combination with kappa-2 carrageenans.
  • Cgn A is a kappa-2 carrageenan as defined herein that was obtained as an alkali processed, clarified extract of Gigartina skottsbergii , essentially haploid (gametophyte) plants. Minor levels (under 5% total) of lambda- and theta-carrageenans from diploid (tetrasporophyte) plants were also present. Cgn A has a low divalent cation content and low potassium cation content as shown in Table 7.
  • Cgn B is a kappa-2 carrageenan that was obtained as an alkali processed, clarified extract of a mixture of Gigartina skottsbergii and Sarcothalia crispata , primarily haploid (gametophyte) plants. About 10-20% (total) of lambda- and theta-carrageenans from diploid (tetrasporophyte) plants were also present.
  • The properties of the kappa-2 carrageenans are shown in Table 7. Viscosity of an aqueous solution at 1.5 wt % solids was measured at 75 o C using a Brookfield LVF viscometer at appropriate speeds and spindles. The properties of 2% water gels prepared using 2 wt% of samples Cgn A-B (#1) without added cations, (#2) with 0.2 wt% added KCl and (#3) with 0.2% added KCl and 0.2% CaCl 2 , respectively, were characterized using a TXTM Texture Analyzer. Gels were tested at 25 o C and the break force (in grams) and the penetration (in millimeters) was recorded.
  • Table 7: Properties of Kappa-2 Carrageenan
  • Cgn A Cgn B
    Cation Exchange Yes No
    Mg, % 0.05 0.05
    Ca, % 0.15 0.45
    K, % 0.67 13.40
    Na, % 7.40 0.90
    Visc, mPs 98 NT
    pH 10.1
    2% water gel
    BF (g) 0
    2% water gel (KCl)
    BF (g) 38
    2% water gel (KCl + CaCl2)
    BF (g) 181
  • TABLE 8: FORMULATIONS AND FILMS USING LV GUAR WITH KAPPA-2 CARRAGEENAN
  • Ex 2-1 Ex 2-2 Ex 2-3
    Ingredients (g)
    Water 836.3 836.3 836.3
    CGN B 0.0 40.5 20.3
    Cgn A 0.0 0.0 20.3
    GUAR ULV 50 90.0 49.5 49.5
    Starch B760 220.8 220.8 220.8
    POTASSIUM CHLORIDE 0.0 0.0 0.0
    SORBITOL SP 264.4 264.4 264.4
    GLYCERIN 88.2 88.2 88.2
    Total weight (g) 1500.0 1500.0 1500.0
    Temp, ° C.* 90 90 90
    VISCOSITY, MPA-S* >50,000 >50,000 >50,000
    Gel, ° C. 47 68-69 69
    Melt, ° C. 78 85-87 86-88
    PH 4.8 5.8 5.9
    Cast film
    Solids, est 42% 45% 42%
    BF (g) <40 239 349
    Dried film (2 hr, 40° C.)
    Solids, est 65% 60% 60%
    BF (g) 722 953 2189
    Dried film (16 hr, 40° C.)
    Solids, est 86% 87% 75%
    BF (g) 4436 7476 6901
    Ex 2-4 Ex 2-5
    Ingredients (g)
    Water 836.3 836.3
    CGN B 0.0 0.0
    Cgn A 40.5 40.5
    GUAR ULV 50 49.5 49.5
    Starch B760 220.8 220.8
    POTASSIUM CHLORIDE 4.5 4.5
    SORBITOL SP 264.4 264.4
    GLYCERIN 88.2 88.2
    Total weight (g) 1500.0 1500.0
    Temp, ° C.* 87 95
    VISCOSITY, MPA-S* >50,000 >50,000
    Gel, ° C. 50 54-65
    Melt, ° C. 67-68 76-83
    PH 5.2 5.2
    Cast film
    Solids, est 40.2% 45%
    BF (g) 130 330
    Dried film (2 hr, 40° C.)
    Solids, est   63% 66%
    BF (g) 1194 1631
    Dried film (16 hr, 40° C.)
    Solids, est   84% 84%
    BF (g) 6276 8733
  • *Temperature and viscosity of the molten mass prior to casting
  • The dried film strength measured after 16 hours, 40 °C for the above inventive gel films is believed to be sufficient to make soft capsules on existing machines. Moreoever, the dried film strength at 2 hours, 40 °C, e.g., of Examples 2-3 to 2-5 also are sufficient to make soft capsules on existing machines. Example 1-2 demonstrates that a 55 to 45 %by weight mixture of guar with kappa-2 carrageenan has increased strength compared to guar alone (Example 2-1). Comparison of Examples 2-4 and 2-5 demonstrates the desirability of maintaining process temperatures for the molten mass above the gel temperature, as Example 2-5 provided finished (dried) gel strengths, when cast at 95 o C, at least 28% higher than a film cast at 87 o C (Example 2-4). The lower gel strength values are reflective of potential pre-gelation during film formation causing a relatively lower gel strength. All films were free of syneresis upon storage and maintained their relative flexibility.
  • Viscosities were generally found to be at or near the maximum for the test equipment and conditions used. Therefore, use of supplementary equipment with the initial hydration/activation apparatus can provide additional shear and solids concentration effects while maintaining process temperatures well above their high solids set/gel temperatures (> 100 o C.). An example of this supplementary equipment, but not limited to, would be an extruder type device sufficient to maintain adequate temperatures and shear necessary to provide the homogeneous mixing and solids concentrations necessary to allow either shaping of the molten mass for direct film or capsule casting or further allow shaping of the molten mass into a desired form such as a film either for use as a film or further processed into other forms and functions.
  • Example 3
  • The properties of films prepared by using blend compositions of low viscosity guar gum ULV50 in combination with either kappa carrageenan or kappa carrageenan and/or iota carrageenan are presented in Tables 9 and Table 10, respectively. The carrageenans used are described below. Carrageenan L was a kappa carrageenan having a viscosity of 10-15 cP.
  • Table 9: Films Using Low Viscosity Guar and Kappa Carrageenan
  • Ex 3-1 Ex 3-2 Ex 3-3 Ex 3-4
    Ingredient (g)
    WATER 836.3 836.3 836.3 836.3
    Cgn L 40.5 40.5 40.5 40.5
    Guar ULV50 49.5 49.5 49.5 49.5
    Starch B760 0 220.8 220.8 0
    Starch B790 220.8 0 0 0
    M-100 0 0 0 220.8
    KCL 0 0 4.5 4.5
    SORBITOL SP 264.4 264.4 264.4 264.4
    GLYCERIN 88.2 88.2 88.2 88.2
    Total weight 1500.0 1500.0 1500.0 1500.0
    Temp, ° C.* 90 90 90 90
    VISCOSITY, MPAS* 16,000 >50,000 36,750 27,100
    As Cast
    Gel, ° C. 36 53 57 56
    Melt, ° C. 61 75-77 76-78 75-78
    pH 5.3 5.2 5.1 5.3
    Cast film
    Solids, est 41.5% 40% 45% 43%
    BF (g) 170 227 g 283 217
    Dried film (2 hrs @
    40 C.)
    Solids, est   69% 65% 64% 66%
    BF (g) 1368 1574 1144 1236
    (16 hours, 40 C.)
    Solids, est.   84% 85% 85% 83%
    BF (g) 5541 7638 7029 5671
  • * Temperature and viscosity of the molten mass prior to casting
  • Use of kappa carrageenan in combination with guar (Example 3-2) increased the film strength for guar alone (Example 2-1).
  • KCl addition (Example 3-3) increased the gel temperature and also the 40% solids gel strength. Further, KCl addition and varying ratios of film forming ingredients will control cast film strength and gel melt temperatures. When kappa carrageenans are used in combination with low viscosity guar of the invention, control of cation divalency desirably prevents/minimizes gel hardening and brittleness.
  • Table 10 reports the compositions and properties of films formed using low viscosity guar ULV50 with kappa and iota carrageenans. Cgn C is an alkali processed clarified kappa carrageenan extract of Kappaphycus alverezii ( Eucheuma cottonii ). Cgn D is an alkali processed clarified iota carrageenan extract of Eucheuma denticulatum ( Eucheuma spinosum ) with low divalency. Both Cgn C and Cgn D have low divalency.
  • Table 10: Films Using LV Guar, Kappa Carrageenan, and Iota Carageenans
  • Ex 3-5 Ex 3-6 Ex 3-7 Ex 3-8
    Ingredient (g)
    WATER 836.3 836.5 836.3 836.3
    Cgn C 0 13.5 27 40.5
    Cgn D 40.5 27 13.5 0
    GUAR ULV 50 49.5 49.5 49.5 49.5
    Starch B760 220.8 220.8 220.8 220.8
    SORNBITOL SP 264.4 264.4 264.4 264.4
    GLYCERIN 88.2 88.2 88.2 88.2
    Total weight 1500.0 1500.0 1500.0 1500.0
    Temp, ° C.* 93 90 90 90
    VISCOSITY, MPA-S* 46,100 41250 41,500 >50,000
    As Cast Film
    Gel, ° C. 70 46 43 53
    Melt, ° C. 85-90 65-66 56-62 75-77
    PH 5.8 5.2 5.4 5.2
    As Cast film
    Solids, est 39% 43% 41% 40%
    BF (g) 102 48 95 227 g
    Dried film (2
    hrs @ 40 C.)
    Solids, est 63% 60% 60% 65%
    BF (g) 1068 282 679 1574
    Dried film
    (16 hours, 40 C.)
    Solids, est 82% 80% 80% 85%
    BF (g) 5915 6067 5549 7638
  • * Temperature and viscosity of the molten mass prior to casting
  • The above examples show how the addition of the other carrageenans added strength to the low viscosity guar film. Further strengthening and control of gel/melt temperatures can be achieved by adding appropriate amounts of cations.
  • Example 4
  • Table 11 presents compositions and properties of films formed using mixtures of guar with potassium alginates and/or carrageenans. Alginates are polyuronate copolymers comprising mannuronate (M) and guluronate(G) units. KAHG is a potassium alginate where the alginate has a high level of G units and is extracted from Laminaria hyperborean . KAHM is a potassium alginate where the alginate has a high level of M units and is extracted from Lessonia nigrescens .
  • TABLE 11: FILMS USING LOW VISCOSITY GUAR, POTASSIUM ALGINATES AND CARRAGEENANS
  • Ex 4-1 Ex 4-2 Ex 4-3
    Ingredient (g)
    WATER 836.3 836.3 836.3
    KAHG 60 60 40.5
    KAHM 0 0 0
    Cgn L 30 30 0
    GUAR ULV50 0 0 49.5
    Starch B760 220.8 220.8 2220.8
    SORBITOL SP 264.4 264.4 264.4
    GLYCERIN 88.2 888.2 88.2
    Total weight 1500.0 1500.0 1500.0
    Temp, ° C.* 90 90 88
    VISCOSITY, MPAS* 26,500 28,650 24,800
    Gel, ° C. 42 41 50-51
    Melt, ° C. 60-65 62-67 60-61
    pH 7.6 7.2 6.3
    Cast Film
    Solids, est 40% 40% 40%
    BF (g) <40 2‘40 2‘40
    Dried film
    (2 hrs @ 40° C.)
    Solids, est 66% 62% 63%
    BF (g) 370 248 445
    Dried film (16 hours, 40 C.)
    Solids, est 81% 79% 85%
    BF (g) 3826 4253 4144
    Ex 4-4 Ex 4-5 Ex 4-6
    Ingredient (g)
    WATER 836.3 836.3 836.3
    KAHG 10.5 0 0
    KAHM 0 60.0 10.5
    Cgn L 30 30.0 30
    GUAR ULV50 49.5 0 49.5
    Starch B760 220.8 220.8 220.8
    SORBITOL SP 264.4 264.4 264.4
    GLYCERIN 88.2 88.2 88.2
    Total weight 1500.0 1500.0 1500.0
    Temp, ° C.* 28,250 42,650 31,250
    Gel, ° C. 53 39 55
    Melt, ° C. 70-74 60-63 65-69
    pH 5.6 7.4 5.9
    Cast Film
    Solids, est 40% 38% 41%
    BF (g) 188 <40 185
    Dried film
    (2 hrs @ 40° C.)
    Solids, est 64% 62% 66%
    BF (g) 1811 502 1265
    Dried film (16 hours, 40 C.)
    Solids, est 80% 77% 80%
    BF (g) 7960 6918 8301
  • * Temperature and viscosity of the molten mass prior to casting
  • Table 12 reports compositions and properties of gel films prepared using blends of low viscosity guar ULV50 with sodium alginates. Protanal® LFR 5/60, Protanal® LF 20/40 and Protanal® SF 120 RB are sodium alginates available from FMC Corporation (Philadelphia, PA).
  • TABLE 12: FILMS USING GUAR AND ALGINATES
  • Ex-4-7 Ex 4-8 Ex 4-9
    Ingredient (g)
    Water 836.3 836.3 836.3
    LFR 5/60 40.5 0 0
    LF 20/40 0 40.5 0
    SF120 RB 0 0 30
    GUAR ULV50 49.5 49.5 45
    B760 220.8 220.8 220.8
    M100 0 0 15.0
    SORBITOL SP 264.4 264.4 264.4
    GLYCERIN 88.2 88.2 88.2
    Total weight 1500.0 1500.0 1500.0
    Temp, ° C.* 90 94 93
    VISCOSITY, MPAS* 31,650 >50,000 >50,000
    Gel, ° C. 50 NA NA
    Melt, ° C. 70-71 >95 >93
    PH 5.6 5.5 5.6
    Vast Film
    Solids, est 40% 40% 40%
    BF (g) <40 102 110
    Dried film
    (2 hrs @ 40° C.)
    Solids, est 60% 64% 67%
    BF (g) 617 1250 1126
    Dried film (16 hours, 40 C.)
    Solids, est 80% 80% 94%
    BF (g) 4780 7701 10,850
  • * TEMPERATURE AND VISCOSITY OF THE MOLTEN MASS PRIOR TO CASTING
  • Table 13 presents compositions and gel films formed from low viscosity guar ULV 50 in combination with propylene glycol alginate. Protanal® ester BV4830 and Protanal® ester SLF3 are propylene glycol alginates available from FMC BioPolymer (Philadelphia PA).
  • TABLE 13: FILMS USING LOW VISCOSITY GUAR AND PROPYLENE GLYCOL ALGINATE
  • Ex 4-10 Ex 4-11 Ex 4-12 Ex 4-13 Ex 4-14
    Ingredient (g)
    Water 836.5 840.3 840.3 840.3 836.3
    BV4830 12.0 0 91.2 0 12.0
    SLF-3 0 85.5 0 114 0
    HEC 0 1.8 1.9 2.4 0
    Cgn L 40.5 0 24 0 40.5
    GUAR ULV50 37.5 30 0 NONE 37.5
    B760 220.8 207.8 207.8 207.8 220.8
    M-100 0 0 0 0
    NA CITRATE 0 2.7 0 3.6
    K CITRATE 0 0 2.9 0
    KCL 0 0 2.4 0
    SORBITOL SP 264.4 248.8 248.8 248.8 264.4
    GLYCERIN 88.2 83.0 83.0 83 88.2
    Temp, ° C. 90 87 90 91 90
    VISCOSITY, 23,100 16,500 25,000 3250 23,100
    MPAS
    Gel, ° C. 46 34-38 43-46 34-35 46
    Melt, ° C. 60-68 62-64 56-62 58-60 60-68
    PH 4.6 4.5 6.3 4.4 4.6
    Cast Film
    Solids, est 41.5% 41 45% 39% 41.5%
    BF (g) 147 440 231 <40 147
    Dried film
    (2 hrs @
    40° C.)
    Solids, est   609% 65% 55% 74%   60%
    BF (g) 592 355 842 1877 592
    Dried film
    (16 hours,
    40 C.)
    Solids, est   80% 77% 78% 85%   80%
    Avg film thick- 0.62 0.60 0.75 0.67 0.62
    ness (mm)
    BF (g) 7214 3317 9599 4677 7214
  • EXAMPLE 5
  • Table 14 lists compositions and properties of gel films prepared using propylene glycol alginate and kappa carrageenan. Protanal® ester BV4830 is a propylene glycol alginates available from FMC Corporation (Philadelphia, PA). HEC is hydroxyethylcellulose. Kappa carrageenan was an alkali processed, clarified extract of Kappaphycus alaverei ( Euchema cottonii ).
  • TABLE 14: PROPYLENE GLYCOL ALGINATE-BASED BLEND COMPOSITIONS
  • Ingredient (g) 5-1 5-2 5-3
    WATER 840.3 836.3 840.3
    BV4830 91.2 49.5 66.0
    HEC 1.9
    KAPPA CGN 24.0 40.5 54.0
    K citrate 2.9
    B760 207.8 220.8 207.8
    SORBITOL SP 264.4 264.4 248.8
    GLYCERIN 88.2 88.2 83
    Temp, ° C.* 91 87 89
    VISCOSITY, MPAS* 24,800 6550 12500
    pH 4.2 3.8 3.9
    Gel, ° C. 59 42-43 43-44
    Melt, ° C. 72-75 54-63 62-64
    Cast film
    Solids, est 45% 38% 36%
    BF (g) 136 89 113
    Dried @ 16 hours, 40° C.
    Solids
    87% 79.8 86.6
    Avg film thickness (mm) 0.72 0.68 0.79
    BF (g) 8838 5244 7638
  • * TEMPERATURE AND VISCOSITY OF MOLTEN MASS PRIOR TO CASTING
  • Table 15 reports compositions and film properties for kappa-2 carrageenan used in combination with propylene glycol alginate and potassium alginate. The kappa-2 carrageenan was an alkali processed, clarified extract of a mixture of Gigartina skottsbergii and Sarcothalia crispata , primarily haploid (gametophyte) plants. About 10-20% (total) of lambda- and theta-carrageenans from diploid (tetrasporophyte) plants were also present.
  • TABLE 15: ALGINATE FILMS WITH KAPPA-2 CARRAGEENAN
  • Ex 5-4 Ex 5-5
    Ingredient (g)
    Water 834.7 834.7
    Kappa-2 Cgn 40.5 54.0
    KAHG 31.5 36
    BV4830 18.0 36.0
    M-100 227.3 227.3
    SORBITOL SP 272.2 272.2
    GLYCERIN 90.8 90.8
    Temp, ° C.* 87 84
    VISCOSITY, MPAS* 4250 1050
    Solids 40 37
    Melt, ° C. 77-78 74-79
    Gel, ° C. 54 52
    pH 4.8 5.5
    Cast film
    (est 40% solids)
    BF (g) 142 168
    DRIED FILM
    (est 80% solids)
    16 hours, 40 C.
    Avg film thickness (mm) 0.67 0.48
    BF (g) 3409 4004
  • * TEMPERATURE AND VISCOSITY OF MOLTEN MASS PRIOR TO CASTING
  • In example 5-4, potassium cations are supplied by the potassium alginate. The potassium cations promote carrageenan double helix formation at a temperature that allows the carrageenan to form its gel film structure. In example 5-5, the additional strength and lower processing viscosity is believed to be due to the higher level of propylene glycol alginate.
  • EXAMPLE 6
  • As set forth below, Cgn A was obtained as an alkali processed, kappa-2 carrageenan clarified extract of Gigartina skottsbergii , essentially haploid (gametophyte) plants and recovered by precipitation with alcohol. Minor levels (under 5% total) of lambda- and theta-carrageenans from diploid (tetrasporophyte) plants were also present.
  • Cgn B was obtained by dissolving Cgn A in water, and recovered by alcohol precipitation and drying. Samples of different molecular weights were obtained by reaction of the dissolved carrageenan with an oxidizing agent to yield Cgn C-F. Sodium hydroxide was added to samples Cgn C-E after the oxidation step and prior to alcohol precipitation to control the pH of the resulting product.
  • The properties of the kappa-2 carrageenans are shown in Table 16. Viscosity of an aqueous solution at 1.5 wt % solids was measured at 75 o C using a Brookfield LVF viscometer at appropriate speeds and spindles. The properties of 2% water gels prepared using 2 wt% of samples Cgn A-F (#1) without added cations, (#2) with 0.2 wt% added KCl and (#3) with 0.2% added KCl and 0.2% CaCl, respectively, were characterized using a TXTM Texture Analyzer. Gels were tested at 25 o C and the break force (in grams) and the penetration (in millimeters) was recorded.
  • Cgn A-F below are examples of the kappa-2 carrageenans that can be used in the present invention.
  • Table 16: Properties of Kappa-2 Carrageenans A-F
  • Cgn A Cgn B Cgn C Cgn D Cgn E Cgn F
    Test
    Oxidation No No Yes Yes Yes Yes
    Treatment
    Mg, % 0.11 0.34 0.19 0.19 0.19 0.19
    Ca, % 0.34 0.29 0.34 0.39 0.52 0.40
    K, % 12.9 8.46 8.59 8.87 8.74 8.95
    Naz, % 0.22 0.42 0.51 0.57 0.65 0.38
    Visc, mPs* 175 144 48 24 14 11
    pH 9.4 9.42 8.93 9.03 9.16 6.7
    2% water gel
  • PF (g) 211 38 21 18 11 12
    Penetration (mm) 7.4 13.9 11.5 9.0 7.8 16.1
    2% water gel (KCl)
    BF (g) 308 162 126 107 70 51
    Penetration (mm) 7.4 9.9 7.8 7.6 7.3 6.1
    2% water gel (KCl + CaCl2)
    BF (g) 487 349 514 445 356 158
    Penetration (mm) 3.6 3.1 6.4 5.3 5.0 1.7
  • *VISCOSITY MEASURED IN 1.5% SOLIDS IN DEIONIZED WATER AT 75°C
  • In Table 17 below, Cgns D and E were formulated as shown and cast as films. The formulations and film properties are reported in Table II. All formulations are considered to be within the scope of the present invention, though some may be more preferable for a particular use than another.
  • Table 17. Kappa-2 Carrageenan Formulations and Film Properties
  • Ex 6-1 Ex 6-2 Ex 6-3 Ex 6-4
    Ingredients (g)
    Water 834.7 834.7 666 497.4
    Cgn D 0 75 75 75
    Cgn E 75 0 0 0
    M-100 227.3 227.3 292.3 357.2
    SORBITOL SP 272.2 272.2 349.9 427.7
    GLYCERIN 90.8 90.8 116.8 142.7
  • Temp, ° C. 81.1 82 85 92
    VISCOSITY, MPAS* 4000 13,700 22,350 >50,000
    Solids (est) 40.1% 40.11% 50.1% 60.0
    Gel, ° C. 55-57 54-55 62 77-78
    Melt, ° C. 73-75 77-80 85 90-92
    As cast film
    BF (g) 312 318 404 476
    BF (g/mm) 280 303 420 448
    Dried film
    (estimated 80% solids)
    (16 hours @ 40° C.)
    Avg film thickness (mm) 1.5 1.0 0.87 1.1
    BF (g) 5755 5220 5613 3218
  • *Temperature and viscosity of the molten mass prior to casting
  • The above Table shows that in Example 6-2 and Example 6-1, the viscosity of the molten mass at processing temperature (13,700 mPas and 4000 mPas, respectively) was controlled by decreasing the molecular weight of Cgn D to CgnE (expressed as viscosity of 24 mPas and 14 mPas, respectively) with an insignificant impact on film properties.
  • The melt temperature of the cast material increased (Examples 6-2, 6-3 and 6-4) as the solids content was increased for a given formulation. In Examples 6-2, 6-3 and 6-4, the gel temperature increased with increasing solids until the gel temperature approached the temperature of the molten mass. Gelation, prior to casting, as indicated by the decreased gel strength of the cast film and the high molten state viscosity (>50,000 mPa) in Example 6-4, is due to the gel temperature approaching the temperature of the molten mass. This indicates the desirability of maintaining the temperature of the molten mass above the gelling temperature during processing if stronger films are desired. Agitation below the gel temperature results in a broken gel structure and decreased strength.
  • Example 7
  • Kappa-2 carrageenan was obtained as an alkali processed, clarified extract of a mixture of Gigartina skottsbergii and Sarcothalia crispata , primarily haploid (gametophyte) plants. About 10-20% (total) of lambda- and theta-carrageenans from diploid (tetrasporophyte) plants was also present. The extract was recovered and subsequently ion exchanged to provide a kappa-2 carrageenan with low divalency. Properties of the low divalent cation kappa-2 carrageenans (Cgn G-J) are shown in Table 18. Cgn G-J are considered to be within the scope of the invention.
  • Table 18: Properties of Low Divalent Cation Kappa-2 Carrageenans
  • Cgn G Cgn H Cgn I Cgn J
  • Cation Exchange Yes YES YES Yes
    Mg, % 0.07 0.02 0.03 0.05
    Ca, % 0.06 0.01 0.16 0.15
    K, % 2.19 1.00 0.00 0.67
    Na, % 5.12 7.70 6.90 7.40
    Visc, mPs 6 18 45 98
    pH 8.12 8.7 9.6 10.1
    2% water gel
    BF (g) 0 0 0 0
    2% water gel (KCl)
    BF (g) 0 13 29 38
    2% water gel (KCl + CaCl2)
    BF (g) 30 98 112 181
  • Film compositions using the low divalent cation content kappa-2 carrageenans of samples Cgn G-J and the corresponding film properties are presented in Table 19. All formulations below are considered to be within the scope of the present invention, though some may be more preferable for a particular use than another.
  • Table 19: Films Using Low Divalent Cation Kappa-2 Carrageenan
  • Ex 7-1 Ex 7-2 Ex 7-3 Ex 7-4
    Ingredients (g)
    Water 834.7 834.7 834.7 834.7
    Cgn J 75 0 75 75
    Cgn I 0 75 0 0
    KCl 0 0 9.0 9.0
    STARCH B790 0 0 0 227.3
    M-100 227.3 227.3 227.3 0
    SORBITOL SP 274.9 274.9 274.9 274.9
    GLYCERIN 91.7 91.7 91.7 91.7
    Temp, ° C.* 89 87 87 87
    VISCOSITY, MPAS* 5800 5800 6250 10,300
    Solids (estimated) 40% 40% 41% 40%
    Melt, ° C. 45-48 43 66-71 70
    Gel, ° C. 35 31 52 48
    As Cast Film
    BF (g) <40 <40 281 237
    Dried film
    Solids,
    (estimated. ˜80%)
    Avg film thickness (mm) 0.97 0.88
    BF (g) 3468 3697 3236 7603
  • * Temperature and viscosity of the molten mass prior to casting
  • The ion exchanged kappa-2 carrageenans (I and J) combined with polyols and maltodextrin (as a bulking agent) provided a relatively weaker cast gel film with negligible break force at 40% solids. This is believed to be due to insufficient amounts of potassium cations that are desired to more fully promote carrageenan double helix formation (i.e., gelling) at temperatures that allow the carrageenan to be the primary structuring agent. Examples 7-1 and 7-2 are gel films having relatively lower melt and gel temperatures. Even though gelation potential is not maximized (due to lower potassium levels), Examples 7-1 and 7-2 show a break force of 3468 and 3697, respectively. Example 7-3 demonstrates the effect of potassium ion addition to the structure formed by the kappa-2 carrageenan in Cgn J. Cast strength, although soft, provided sufficient strength for film removal from the casting plate. Structure development by Cgn J, with the addition of potassium ions, is confirmed by the increase in melt and gel temperatures in Example 7-3 as compared to Example 7-1. Break force of the dried film remained comparable to Examples 7-1 and 7-2.
  • Example 7-4 demonstrates the effect of replacing maltodextrin in Example 7-3 by a modified starch (B790). While viscosity was increased, the gel and melt temperatures remained relatively similar to Example 7-3 which contained the maltodextrin. The cast film strength of Example 7-4 was also relatively equal to Example 7-3. The dried film strength of Example 2-4 was more than doubled as compared to Example 7-3. This clearly indicates the structural synergy between the starch and kappa-2 carrageenan, when both are present with potassium cations (i.e., gelling ions for kappa-2 carrageenan). Potassium ions may be provided by direct addition of inorganic salts, organic salts, or combinations thereof or contained within additional ingredients. Use of kappa-2 carrageenan containing residual processing salts can promote the desired gel formation conditions that maximizes gel structure and starch synergy. A homogeneous kappa-2 carrageenan/starch gel structure was formed by casting the molten mass at sufficiently high temperatures to prevent pre-gelation.
  • Additional formulations of the present invention are provided immediately below.
  • Table 20: Kappa-2 Carrageenan Films
  • Ex 7-5 Ex 7-6 Ex 7-7
    Ingredients (g)
    Water 834.7 834.7 825
    Cgn H 61.4 0 0
    Cgn G 0 0 90
    Cgn I 0 75.0 0
    Calcium sulfate dihydrate 1.7 0 0
    Potassium chloride 0 15.0 0
    STARCH B760 0 0 225
    M-100 227.3 227.3 0
    SORBITOL SP 275.4 272.2 272.2
    GLYCERIN 91.9 90.8 90.8
  • Temp, ° C. 82 88 75
    VISCOSITY, MPAS* 6,500 16,150 18,250
    Solids, estimated 39 42 40
    Melt, ° C. 74-77 85 62-65
    Gel, ° C. 56 60-65 42
    PH 5.8 6.9 6.9
    AS CAST FILM
    BF (g) at ˜40% 338 302 117
    Dried 2 hrs @ 40 C.
    BF (g) at ˜60% 766 NT 536
    Dried 16 hours @ 40° C.
    Avg film thickness (mm) 0.62
    BF (g) at ˜80% 3227 4470 6073
  • NT = not tested
  • * Temperature and viscosity of the molten mass prior to casting
  • Example 7-5 was prepared to have equivalent cation content with example 5-1. Both samples show the same gel melt properties. The higher molecular weight of Cgn E (14 cps) in Example 5-1 provided more structural support to the gel film as compared to Cgn H (6 cps) in Example 7-5, as is shown by the higher break force of the dried film. The higher dried film strength of the Example 7-7 shows that use of modified starch in combination with low molecular weight kappa-2 carrageenan provides overall film structure and indicates complexation of kappa-2 carrageenan with the starch.
  • Example 8
  • A heated and mixed composition, e.g., any of those in Examples 1-7, is formed into a film in a conventional polymer film casting machine by transferring a controlled thickness of the molten composition onto a temperature controlled rotating drum operated at a temperature such that the film formed is suitable for handling and processing in subsequent operations. Downstream from the film forming operation, films are fed through a series of rollers to counter-rotating dies in a conventional gelatin capsule machine to form, cut and fill capsules of various sizes. During this process, two film surfaces are brought into contact under fusing conditions (i.e., time under sufficient local pressure and local temperature to fuse them together). The formed capsules are discharged for further processing. Recovered capsules have sufficient mechanical strength to withstand handling, packaging, and storage conditions.
  • Example 9
  • Soft Capsule Example
  • Soft gel capsules (7.5 oval) containing mineral oil (Formula A below) were produced using a Technophar SGM1010 soft capsule machine with 7.25 inch long by 4 inch diameter dies. Preparation of the molten mass used to form the capsule shell was as follows: 11.35 lbs of kappa-2-carrageenan was added to a charge of 33.89 lbs of glycerin in a Ross DS40 jacketed vacuum mixer and dispersed at maximum speed for 5 minutes. An additional 11.35 lbs of kappa-2 carrageenan was added to the mixture and dispersed an additional 5 minutes. A premix of 50 lbs of PureCote B790 modified starch in 94.1 lbs of deionized water was then charged to the mixer. The mixer hood was closed and a 26 inch vacuum was pulled to remove air. The contents were mixed for 30 minutes with the planetary mixer at maximum speed and the disperser at 1/3 maximum speed. The vacuum was locked in and the contents of the mixer were then mixed while heating to 90 o C by applying low pressure steam (< 10 psig) to the mixer jacket. After reaching a temperature of 90 o C, the disperser speed was gradually increased to 2/3 maximum while maintaining the molten mass at a temperature of at least 90 o C for 45 minutes. The molten mass was dispensed using a pressurized plate to urge the molten mass to flow as needed from the Ross mixer through a temperature controlled, electrically heated (~125 o C) flexible hose to the covered spreader box. The cast films formed in the spreader box were continuous and even. The films were transported by rollers to the capsule forming dies where capsules were formed, filled with mineral oil and sealed. The capsule sealing temperature was 62 o C and the sealing pressure was ~2 bars. The ability to seal was improved as the thickness of the ribbon was decreased from 0.28 inches to 0.16 inches. Capsules were tunnel dried for 72 hours at 80 o F and 19% RH. The integrity of the capsule seal remained good after drying. The cast film made from this formulation was dark amber and cloudy with a slight seaweed odor. The break force of the film (0.3 mm in thickness) was 310 g at 58% solids. The breakforce of the film after drying overnight at 40 o C and 40% RH (~80% solids) was 3309 g. See A in Table 21 below.
  • Additional soft capsules (Formula B below) encapsulating mineral oil were produced according to the above process and equipment using a second formulation comprising 39.7 lbs of Sorbitol SP, 59.5 lbs of glycerin, 19.6 lbs of sodium ion exchanged kappa-2 carrageenan, 44.6 Lbs of PureCote B760 starch and 92.6 pounds of water. The Sorbitol SP was added in the starch/water premix. Films produced using this formulation were odorless, transparent and a medium color. The as-cast film had a thickness of 0.6 mm and a break force strength of 263 g at 55% solids. A film sample which was dried overnight at 40 o C and 40% RH (~80% solids) had a thickness of 0.7 mm and a breakforce of 6463 g. The as-cast film was more elastic and stretched when fed over the rollers into the capsule dies. Capsules were formed using a capsule seal temperature of 42 o C and a seal pressure of 0.5 bar. Mineral oil was encapsulated
  • The capsules were evaluated for weight, film thickness for each half of the capsule, and burst strength. Burst strength was measured by compressing the capsule to failure. The compression probe had a speed of 1 mm/sec. Ten capsules were tested for each condition. The shell strength is reported as the capsule burst strength with the seam horizontally positioned. The seam strength was measured for 10 capsules with the seam vertically positioned. Results are shown in Table 21. Both kappa-2-carrageenen films were flexible as indicated by the burst distance and produced a strong capsule seal as indicated by a capsule burst strength that was approximately the same for the capsule shell and the capsule seam and that the capsule did not fail at the seam but at the tip on the seam (away from the point of pressure).
  • Table 21: Capsule Properties
  • Capsule
    Capsule Weight, Film w/fill weight Thickness film 1/film 2,
    Formula (mg) (mg) mm
    Formula 471 151/320 357/312
    A
    Formula 499 187/312 420/370
    B
    Seam
    Shell burst burst
    Capsule distance Shell strength, distance Seam strength,
    Formula Mm Newtons mm Newtons
    Formula 6.3 206 6.3 210
    A
    Formula 5.3 124 5.1 105
    B
  • While the invention has been described in detail and with reference to specific embodiments thereof, it will be apparent to one skilled in the art that various changes and modifications can be made therein without departing from the spirit and scope thereof.

Claims (53)

1. A process for making homogeneous, thermoreversible gel films comprising the steps of:
(i) heating, hydrating, mixing, solubilizing, and, optionally, de-aerating a film forming composition in an apparatus providing sufficient shear, temperature and residence time to form a homogeneous molten composition, wherein said temperature is at or above the solubilizing temperature of said composition;
(ii) feeding said molten composition into at least one of a mixer, pump or devolatilizer; and
(iii) cooling said homogeneous molten composition at or below its gelling temperature to form said gel films.
2. The process of claim 1, wherein said film forming composition comprises at least one hydrocolloid film former and optionally a plasticizer, bulking agent, pH control agent and second film former.
3. The process of claim 1, wherein said apparatus is a Ross mixer, Stephan processor, extruder, jet cooker or fluid mixing apparatus.
4. The process of claim 1, wherein said molten composition is at least 50% solids.
5. The process of claim 1, wherein said molten composition is at least 60% solids.
6. The process of claim 1, wherein said molten composition is at least 70% solids.
7. The process of claim 1, wherein said molten composition is at least 80% solids.
8. The process of claim 1, wherein said molten composition is at least 90% solids.
9. The process of claim 1, wherein said gel film has a break force of at least 1,000 grams.
10. The process of claim, 1 wherein said gel film has a break force strength of at least 2,500 grams.
11. The process of claim 1, wherein said gel film has a break force strength of at least 4,000 grams.
12. The process of claim 1, wherein said gel film has a break force strength of at least 5,000 grams.
13. The process of claim 1, wherein said gel film has a break force strength of at least 6,000 grams.
14. The process in any of claims 1-13, wherein said molten composition is fed into at least one of a pump, mixer or devolatilizer.
15. The process of claim 2, wherein said hydrocolloid is at least one member selected from the group consisting of a carrageenan, alginate, glucomannan or galactomannan, said plasticizer is at least one member selected from the group consisting of glycerin, sorbitol, maltitol, lactitol, and polyalkylene glycols; said second film former is at least one member selected from the group consisting of a starch, starch derivative, starch hydrozylate, cellulose gum, hydrocolloid, an alkylcellulose ether and a modified alkyl cellulose ether; and said bulking agent is at least one member selected from the group consisting of microcrystalline cellulose, microcrystalline starch, starch, starch derivatives, inulin, and starch hydrozylates.
16. The process of claim 15, wherein said carrageenan is at least one member selected from the group consisting of iota carrageenan, kappa carrageenan and kappa-2 carrageenan; said alginate is propylene glycol alginate, said glucomannan is konjac and said galactomannan is guar gum.
17. The process of claim 1, wherein said solubilizing temperature is greater than the boiling point of the homogeneous molten composition at atmospheric pressure and said heating, hydrating, mixing and solubilizing is conducted above atmospheric pressure.
18. The process in any of claims 1 to 17, wherein said devolatilization is conducted in an extruder.
19. The process in any of claims 1 to 17, wherein said molten composition is fed directly into said mixer, deareated, depressurized and pumped prior to cooling to or below the molten composition's gelling temperature.
20. A homogeneous, thermoreversible, high solids, low moisture film made from the process in any of claims 1-19.
21. A process for making soft capsules comprising the steps of:
(i) heating, hydrating, mixing, solubilizing and, optionally, de-aerating a high solids, low moisture film forming composition in an apparatus providing sufficient shear, temperature and residence time to form a homogeneous molten composition, wherein said temperature is at or above the solubilizing temperature of said composition;
(ii) feeding said molten composition into at least one of a mixer, pump or devolatilizer;
(iii) cooling said molten composition to or below the gelling temperature of the molten composition to form a homogeneous, thermoreversible gel film; and
(iii) making soft capsules from said gel film.
22. The process of claim 21, wherein said film forming composition comprises at least one hydrocolloid and optionally a plasticizer, bulking agent, a pH control agent and second film former.
23. The process of claim 21, wherein said apparatus is a Ross mixer, extruder, Stephan processor, jet cooker or fluid mixing apparatus.
24. The process of claim 21, wherein said molten composition is at least 50% solids.
25. The process of claim 21, wherein said molten composition is at least 60% solids.
26. The process of claim 21, wherein said molten composition is at least 70% solids.
27. The process of claim 21, wherein said molten composition is at least 80% solids.
28. The process of claim 21, wherein said molten composition is at least 90% solids.
29. The process of claim 21, wherein said gel film has a break force of at least 1,000 grams.
30. The process of claim 21, wherein said gel film has a break force strength of at least 2,500 grams.
31. The process of claim 21, wherein said gel film has a break force strength of at least 4,000 grams.
32. The process of claim 21, wherein said gel film has a break force strength of at least 5,000 grams.
33. The process of claim 21, wherein said gel film has a break force strength of at least 6,000 grams.
34. The process in any one of claims 21-33, wherein said molten composition is fed into an extruder having at least one of a pump, mixer and devolatilizer.
35. The process of claim 22, wherein said hydrocolloid is at least one member selected from the group consisting of a carrageenan, alginate, glucomannan or galactomannan, said plasticizer is at least one member selected from the group consisting of glycerin, sorbitol, maltitol, lactitol, and polyalkylene glycols; said second film former is at least one member selected from the group consisting of a starch, starch derivative, starch hydrozylate, cellulose gum, kappa carrageenan; iota carrageenan, kappa-2 carrageenan, alginates, propylene glycol alginate, polymannan gums, pullulan, dextran, gellan, pectin, an alkylcellulose ether and a modified alkyl cellulose ether; and said bulking agent is at least one member selected from the group consisting of microcrystalline cellulose, microcrystalline starch, starch, starch derivatives, inulin, and starch hydrozylates.
36. The process of claim 35, wherein said carrageenan is at least one member selected from the group consisting of iota carrageenan, kappa carrageenan and kappa-2 carrageenan; said alginate is propylene glycol alginate, said glucomannan is konjac and said galactomannan is guar gum.
37. The process of claim 21, wherein said solubilizing temperature is greater than the boiling point of the homogeneous molten composition at atmospheric pressure and said heating, hydrating, mixing and solubilizing is conducted above atmospheric pressure.
38. The process in any one of claims 21 to 37, wherein said devolatilization is conducted in an extruder.
39. The process in any one of claims 21 to 37, wherein said molten composition is fed directly into said mixer, deareated, depressurized and pumped prior to cooling to or below the molten composition's gelling temperature.
40. Soft capsules made by the process in any one of claims 21 to 39.
41. A process for making a solid dosage form comprising a fill material encapsulated by a homogeneous, thermoreversible gel film comprising the steps of:
(i) preparing the homogeneous, thermoreversible gel film in accordance with the process in any one of claims 1-19; and
(ii) encapsulating said fill material in said gel film.
42. The process of claim 41, wherein said fill material is a powder, tablet, caplet, microcapsule or capsule.
43. The solid form of claim 41, wherein said solid form is a hard capsule.
44. A process for preparing a homogeneous gel film delivery system comprising an active substance and a homogeneous, thermoreversible gel film, comprising the steps of:
(i) preparing the molten composition in any one of claims 1-19; and
(ii) adding an effective amount of an active substance prior to or after formation of the molten composition: and
(iii) cooling said molten composition containing said active substance at or below its gelling temperature to form said gel films containing said active substance.
45. The process of claim 44, wherein said active substance is at least one of an oral care agent, a breath freshening agent, a pharmaceutical agent, a nutraceutical agent, a salivary stimulant agent, a vitamin, a mineral, a coloring agent, a sweetener, a flavorant, a fragrance, a food.
46. A delivery system made by the process of claim 44.
47. A process for making homogeneous, thermoreversible gel films comprising the steps of:
(i) heating, hydrating, mixing, solubilizing, and, optionally, deareating a film forming composition in an apparatus providing sufficient shear, temperature and residence time to form a homogeneous molten composition, wherein said temperature is at or above the solubilizing temperature of said composition; and
(ii) cooling said homogeneous molten composition at or below its gelling temperature to form said gel films.
48. The process of claim 47, wherein said apparatus is a Ross mixer.
49. A process for making soft capsules comprising the steps of:
(i) heating, hydrating, mixing, solubilizing and, optionally, deaerating a high solids, low moisture film forming composition in an apparatus providing sufficient shear, temperature and residence time to form a homogeneous molten composition, wherein said temperature is at or above the solubilizing temperature of said composition;
(ii) cooling said molten composition to or below the gelling temperature of the molten composition to form a homogeneous, thermoreversible gel film; and
(iii) making soft capsules from said gel film.
50. The process of claim 49, wherein said apparatus is a Ross mixer.
51. The process of claim 2, wherein said film forming composition does not contain a plasticizer.
52. The process of claim 2, wherein said film forming composition contains said bulking agent, and said at least one hydrocolloid film former is carrageenan and said bulking agent is corn syrup.
53. A homogeneous, thermoreversible gel film made from the process of claims 51 or 52, wherein said gel film has a solids content of a least 80% by weight of all components in said gel film.
US10/824,689 2003-04-14 2004-04-14 Process for making gel films Abandoned US20050084516A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/824,689 US20050084516A1 (en) 2003-04-14 2004-04-14 Process for making gel films
US11/954,958 US20080089934A1 (en) 2003-04-14 2007-12-12 Process for making gel films

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US46278303P 2003-04-14 2003-04-14
US46279303P 2003-04-14 2003-04-14
US46275803P 2003-04-14 2003-04-14
US46278503P 2003-04-14 2003-04-14
US46272103P 2003-04-14 2003-04-14
US46279203P 2003-04-14 2003-04-14
US46261703P 2003-04-14 2003-04-14
US46279403P 2003-04-14 2003-04-14
US10/824,689 US20050084516A1 (en) 2003-04-14 2004-04-14 Process for making gel films

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/954,958 Continuation US20080089934A1 (en) 2003-04-14 2007-12-12 Process for making gel films

Publications (1)

Publication Number Publication Date
US20050084516A1 true US20050084516A1 (en) 2005-04-21

Family

ID=33304300

Family Applications (3)

Application Number Title Priority Date Filing Date
US10/824,860 Active 2028-02-20 US7807194B2 (en) 2003-04-14 2004-04-14 Homogeneous, thermoreversible gel film containing kappa-2 carrageenan and soft capsules made therefrom
US10/824,689 Abandoned US20050084516A1 (en) 2003-04-14 2004-04-14 Process for making gel films
US11/954,958 Abandoned US20080089934A1 (en) 2003-04-14 2007-12-12 Process for making gel films

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/824,860 Active 2028-02-20 US7807194B2 (en) 2003-04-14 2004-04-14 Homogeneous, thermoreversible gel film containing kappa-2 carrageenan and soft capsules made therefrom

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11/954,958 Abandoned US20080089934A1 (en) 2003-04-14 2007-12-12 Process for making gel films

Country Status (10)

Country Link
US (3) US7807194B2 (en)
EP (8) EP1622588A2 (en)
JP (8) JP4558721B2 (en)
KR (4) KR20060011953A (en)
BR (7) BRPI0409336A (en)
CA (5) CA2522297A1 (en)
IL (1) IL171291A (en)
MX (4) MXPA05011029A (en)
PL (1) PL1628643T3 (en)
WO (9) WO2004091538A2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050196437A1 (en) * 2004-03-02 2005-09-08 Bednarz Christina A. Hard capsules
US20050196436A1 (en) * 2004-03-02 2005-09-08 Arjnarong Chantranukul Blends of different acyl gellan gums and starch
US20080138402A1 (en) * 2006-11-17 2008-06-12 Zhixin Li Highly inhibited starch fillers for films and capsules
US20090217462A1 (en) * 2008-02-08 2009-09-03 Holzhauer Fred Consumer product packets with enhanced performance
US20090249562A1 (en) * 2008-04-02 2009-10-08 Mark Robert Sivik Fabric color rejuvenation composition
US20100061180A1 (en) * 2008-09-05 2010-03-11 United States Gypsum Company Efficient wet starch preparation system for gypsum board production
US8262820B2 (en) 2006-04-28 2012-09-11 United States Gypsum Company Method of water dispersing pregelatinized starch in making gypsum products

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7887838B2 (en) * 2002-01-18 2011-02-15 Banner Pharmacaps, Inc. Non-gelatin film and method and apparatus for producing same
KR20060011953A (en) * 2003-04-14 2006-02-06 에프엠씨 코포레이션 Process for making gel films
EP1621211A1 (en) * 2003-05-02 2006-02-01 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Soft capsule film and soft capsule
DE102005023258A1 (en) * 2004-11-16 2006-11-23 Fan Separator Gmbh Rotary drum for aerobic heating of free-flowing solids
SE530184C2 (en) * 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesive pharmaceutical film composition containing low viscous alginates
AU2006329819A1 (en) * 2005-12-27 2007-07-05 Monosol Rx Llc pH modulated films for delivery of actives
DK3095447T3 (en) 2006-02-03 2022-01-31 Opko Renal Llc TREATMENT OF VITAMIN D INSUFFICIENTS AND DEFICIENCY WITH 25-HYDROXYVITAMIN D2 AND 25-HYDROXYVITAMIN D3
CL2007001628A1 (en) * 2006-06-06 2008-01-11 Fmc Corp Chemical composition comprising i) kappa-2-carrageenan, ii) a minimum of 70% sodium by weight of all cations in that composition and iii) between 0-25% of a free salt, with a viscosity of 20 to 40 cps; solid form; homogeneous gel film, fearreversible; coating composition.
US20070281065A1 (en) * 2006-06-06 2007-12-06 Modliszewski James J Kappa-2 carrageenan composition and products made therefrom
PL2679228T3 (en) 2006-06-21 2018-07-31 Opko Ireland Global Holdings, Ltd. Therapy using vitamin D repletion agent and vitamin D hormone replacement agent
US8900558B2 (en) 2006-06-30 2014-12-02 Colgate-Palmolive Company High fluoride ion oral care composition and method for maintaining anticaries activity
JP2008072915A (en) * 2006-09-19 2008-04-03 Dhc Co Film-like food
KR100846494B1 (en) * 2006-09-26 2008-07-17 삼성전자주식회사 Primer set for amplifying target sequences of Helicobacter pylori method for detecting Helicobacter pylori using the primer set and kit for detecting Helicobacter pylori comprising the primer set
JP5379121B2 (en) * 2007-04-05 2013-12-25 ユニバーシティ・オブ・カンザス Fast dissolving pharmaceutical composition comprising pullulan
US8900629B2 (en) 2007-04-05 2014-12-02 University Of Kansas Rapidly dissolving pharmaceutical compositions comprising pullulan
PL2481400T3 (en) 2007-04-25 2015-04-30 Opko Ip Holdings Ii Inc Oral controlled release compositions comprising vitamin D compound and waxy carrier
CN104257667B (en) 2007-04-25 2019-06-04 欧普科Ip 控股Ii 有限公司 Treat vitamin d insufficiency and shortage, secondary hyperparathyroidism and vitamin D-responsive diseases method and composition
EP3225243A1 (en) 2007-04-25 2017-10-04 Opko Renal, LLC Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
JP5871447B2 (en) * 2007-11-30 2016-03-01 花王株式会社 GIP secretion inhibitor
ES2954932T3 (en) 2008-04-02 2023-11-27 Eirgen Pharma Ltd Useful methods, compositions, uses and kits for vitamin D deficiency and related disorders
EP2108677A1 (en) 2008-04-10 2009-10-14 Swiss Caps Rechte und Lizenzen AG Thermoplastic starch-containing materials
US20100028521A1 (en) * 2008-07-25 2010-02-04 Tic Gums, Inc. Gum arabic replacements in: (1) panning, confections, adhesion & coatings; (2) edible films and flavor encapsulation; and (3) lithography
ITMI20081450A1 (en) * 2008-08-04 2010-02-05 Biofarmitalia Spa SOLID RAPID DISSOLUTION FILM IN LIQUIDS
CA2737880A1 (en) * 2008-09-26 2010-04-01 Sankyo Co., Ltd. Method for manufacturing soft capsule and apparatus for manufacturing the same
FR2946227B1 (en) * 2009-06-03 2011-07-22 Ds France Sas SAUCISING COATING COMPRISING BOTH A CELLULOSE DERIVATIVE AND A GALACTOMANNAN.
JP4822299B2 (en) * 2009-06-19 2011-11-24 富士カプセル株式会社 Soft capsule and method for producing the same
TR201904204T4 (en) * 2009-09-10 2019-04-22 Dupont Nutrition Usa Inc Jointless alginate capsules.
WO2011119287A1 (en) * 2010-03-26 2011-09-29 Dow Global Technologies Llc Melt-extruded film
CN105796530A (en) 2010-03-29 2016-07-27 赛特克罗公司 Methods and compositions for reducing parathyroid levels
MX2013000703A (en) * 2010-07-19 2014-07-24 Procaps Sa Apparatus and process for encapsulating capsules or other solid dosage forms within capsules.
US10206765B2 (en) 2011-01-24 2019-02-19 Leonard G. Lorch Dental floss
US9277977B2 (en) 2011-01-24 2016-03-08 Leonard G. Lorch Dental floss
US9277976B2 (en) 2011-01-24 2016-03-08 Leonard G. Lorch Dental floss
US8992971B2 (en) 2011-04-20 2015-03-31 Suheung Capsule Co., Ltd. Non-animal soft capsule shell composition having improved disintegration and shell hardness
US8877259B2 (en) 2012-02-09 2014-11-04 Mary Kay Inc. Cosmetic formulation
US9320297B2 (en) * 2012-03-22 2016-04-26 Lemniscate Innovations Llc Spherification/reverse spherification automated and integrated system and method
CN104968374A (en) * 2012-10-26 2015-10-07 陶氏环球技术有限责任公司 Aqueous fragrance release gels
CN105263462B (en) 2013-03-15 2019-11-22 帕西恩软胶公司 Gelatin-free enteric soft capsules
KR101847947B1 (en) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 Stabilized modified release vitamin d formulation
NL2010552C2 (en) 2013-04-02 2014-10-06 Paxtree Ltd Composition as auxiliary means for oral medication.
WO2015084358A1 (en) * 2013-12-05 2015-06-11 Empire Technology Development Llc Thermostatic materials, methods of making, and uses thereof
EP3193925A2 (en) 2014-08-07 2017-07-26 OPKO Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin d
US20170119680A1 (en) * 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
MX2018011820A (en) 2016-03-28 2019-01-24 Opko Ireland Global Holdings Ltd Methods of vitamin d treatment.
KR101973057B1 (en) * 2017-04-13 2019-04-26 주식회사 케이티앤지 Capsule for cosmetics and method of menufacturing thereof
KR101874512B1 (en) * 2017-06-29 2018-07-04 농업회사법인(주)강림오가닉 Soft Capsules method with mixture of Vegetable Omega-3 in Perilla Oil and Vitamin C and Soft Capsules
US11896720B2 (en) 2017-09-26 2024-02-13 Captek Softgel International Orally available articles containing at least one stabilized supplement therein
US10711119B2 (en) * 2018-01-10 2020-07-14 Cp Kelco Aps Carrageenan-based compositions for films and capsules
CN110075081A (en) * 2019-06-12 2019-08-02 江苏艾兰得营养品有限公司 A kind of soft capsule and preparation method thereof and purposes
CN111388442A (en) * 2020-03-24 2020-07-10 广州普正生物科技有限公司 Gel candy type plant soft capsule
MX2023003016A (en) 2020-09-22 2023-04-10 Swimc Llc Chitosan-containing coating compositions.
KR102294072B1 (en) * 2020-11-19 2021-08-26 (주)알피바이오 Composition for plant-based chewable soft capsule and plant-based chewable soft capsule using the same
EP4280894A1 (en) 2021-01-25 2023-11-29 DuPont Nutrition Biosciences ApS A stabilizer composition comprising microcrystalline cellulose
FR3122575A1 (en) * 2021-05-05 2022-11-11 Gabrielle De La Goublaye De Nantois Cosmetic soft capsules
WO2023008567A1 (en) * 2021-07-30 2023-02-02 三生医薬株式会社 Capsule shell composition and capsule obtained using same
WO2023025728A1 (en) * 2021-08-27 2023-03-02 Unilever Ip Holdings B.V. Films and capsules
WO2023025769A1 (en) * 2021-08-27 2023-03-02 Unilever Ip Holdings B.V. Films and capsules
WO2023025917A1 (en) * 2021-08-27 2023-03-02 Unilever Ip Holdings B.V. Films and capsules
WO2023025649A1 (en) * 2021-08-27 2023-03-02 Unilever Ip Holdings B.V. Films and capsules
WO2023025919A1 (en) * 2021-08-27 2023-03-02 Unilever Ip Holdings B.V. Films and capsules
WO2023025768A1 (en) * 2021-08-27 2023-03-02 Unilever Ip Holdings B.V. Films and capsules
WO2023072546A1 (en) * 2021-10-25 2023-05-04 Unilever Ip Holdings B.V. Films and capsules

Citations (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2802000A (en) * 1953-08-13 1957-08-06 Nat Starch Products Inc Ungelatinized cold water soluble starch ethers
US2813093A (en) * 1953-06-10 1957-11-12 Nat Starch Products Inc Ungelatinized tertiary amino alkyl ethers of amylaceous materials
US2825727A (en) * 1954-05-19 1958-03-04 Nat Starch Products Inc Ungelatinized starch products of improved properties and method of making the same
US2876217A (en) * 1956-12-31 1959-03-03 Corn Products Co Starch ethers containing nitrogen and process for making the same
US3058827A (en) * 1960-02-09 1962-10-16 Eastman Kodak Co Dialdehyde starch as gelatin hardener
US3094517A (en) * 1958-12-29 1963-06-18 Marine Colloids Inc Process for treating a polysaccharide of seaweeds of the gigartinaceae and solieriaceae families
US3176003A (en) * 1961-08-15 1965-03-30 Marine Colloids Inc Selective extraction of hydrocolloid fractions from sea plants
US3329509A (en) * 1959-12-01 1967-07-04 Ile Des Produits Lifine Soc Ci Food wrapping membrane
US3378546A (en) * 1965-03-03 1968-04-16 American Maize Prod Co Hydroxypropyl starch ether
US3499962A (en) * 1967-08-24 1970-03-10 Nat Starch Chem Corp Encapsulation of water insoluble materials
US3505110A (en) * 1967-01-18 1970-04-07 Penick & Ford Ltd Sugar products prepared from hydroxypropylated starch
US3607394A (en) * 1969-05-29 1971-09-21 Felix Joseph Germino Novel pregelatinized starches and process for preparing same
US3865603A (en) * 1972-07-17 1975-02-11 Nat Starch Chem Corp Modified starch-extended gelatin compositions
US3956173A (en) * 1974-07-05 1976-05-11 Hercules Incorporated Preparation of gels based on carrageenan
US3962482A (en) * 1975-03-24 1976-06-08 Uniroyal, Ltd. Clear, elastic, water gels based on carrageenan
US4009291A (en) * 1974-03-25 1977-02-22 General Foods Corporation Cold water soluble stable bulked starch
US4026986A (en) * 1975-05-22 1977-05-31 The Dow Chemical Company Capsule shell
US4096327A (en) * 1977-01-05 1978-06-20 Fmc Corporation Modified kappa-carrageenan
US4129134A (en) * 1975-04-14 1978-12-12 Philip Morris Incorporated Smoking article
US4276320A (en) * 1980-01-25 1981-06-30 Fmc Corporation Compositions and method for preparing dessert gels
US4443486A (en) * 1980-04-09 1984-04-17 Fmc Corporation Modified extractive of Eucheuma cottonii seaweed and composition containing same
US4600439A (en) * 1982-10-12 1986-07-15 Roquette Freres Composition and process for coating paper and cardboard process for preparing the compositions and paper and cardboard so obtained
US4615897A (en) * 1985-02-25 1986-10-07 Nabisco Brands, Inc. Cold water soluble gelatin
US4626288A (en) * 1985-01-10 1986-12-02 National Starch And Chemical Corporation Starch derivatives forming reversible gels
US4632848A (en) * 1981-06-23 1986-12-30 Roquette Freres Composition and process for forming a temporary protective coating on an article and article so-protected
US4643894A (en) * 1984-07-24 1987-02-17 Colorcon, Inc. Maltodextrin coating
US4738724A (en) * 1983-11-04 1988-04-19 Warner-Lambert Company Method for forming pharmaceutical capsules from starch compositions
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
US4828841A (en) * 1984-07-24 1989-05-09 Colorcon, Inc. Maltodextrin coating
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5002934A (en) * 1986-11-24 1991-03-26 Van Den Bergh Foods Co., Division Of Conopco, Inc. Aqueous gel comprising carrageenan
US5051304A (en) * 1986-12-18 1991-09-24 Societe Anonyme: Mero Rousselot Satia Microcapsules based on gelatin and polysaccharides and process for obtaining same
US5089307A (en) * 1989-05-23 1992-02-18 Mitsubishi Rayon Co., Ltd. Edible film and method of making same
US5224989A (en) * 1991-11-18 1993-07-06 Eva Likarova Film-forming dispersion for a protective coating of drug and food containing articles and objects
US5264223A (en) * 1990-03-29 1993-11-23 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5334640A (en) * 1992-04-08 1994-08-02 Clover Consolidated, Ltd. Ionically covalently crosslinked and crosslinkable biocompatible encapsulation compositions and methods
US5342626A (en) * 1993-04-27 1994-08-30 Merck & Co., Inc. Composition and process for gelatin-free soft capsules
US5431917A (en) * 1992-10-08 1995-07-11 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5451673A (en) * 1993-04-23 1995-09-19 The United States Of America As Represented By The Secretary Of Agriculture Films fabricated from mixtures of pectin and starch
US5484598A (en) * 1992-08-18 1996-01-16 R.P. Scherer Corporation Soft gelatin medicament capsules with gripping construction
US5525368A (en) * 1989-02-10 1996-06-11 Alko Group Ltd. Degraded polysaccharide derivatives and foodstuffs containing same
US5549983A (en) * 1996-01-22 1996-08-27 Alliedsignal Inc. Coflow planar fuel cell stack construction for solid electrolytes
US5554385A (en) * 1990-11-28 1996-09-10 R. P. Scherer Corporation High amylose starch substituted gelatin capsules
US5569466A (en) * 1995-05-17 1996-10-29 R. P. Scherer Corporation Fill compositions for soft elastic gel capsules
US5587412A (en) * 1992-03-31 1996-12-24 National Starch And Chemical Investment Holding Corporation Esterified starch composition
US5614217A (en) * 1995-06-07 1997-03-25 R.P. Scherer Corporation Capsule shell formulation to produce brittle capsules
US5646206A (en) * 1993-04-23 1997-07-08 The United States Of America As Represented By The Secretary Of Agriculture Films fabricated from mixtures of pectin and poly(vinyl alchohol)
US5672699A (en) * 1995-09-06 1997-09-30 National Starch And Chemical Investment Holding Corporation Process for preparation of hydrophobic starch derivatives
US5726008A (en) * 1996-09-18 1998-03-10 Eastman Kodak Company Photographic elements with improved vehicles
US5756123A (en) * 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
US5804243A (en) * 1994-12-23 1998-09-08 Cpc International Inc. Process for making low-fat, cake donuts
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
US5817323A (en) * 1993-06-28 1998-10-06 R.P. Scherer Corporation Soft gelatin capsule shell compositions
US5820259A (en) * 1996-07-30 1998-10-13 Q-Jet Dsi, Inc. Dual control mixing jet cooker
US5932639A (en) * 1996-05-06 1999-08-03 National Starch And Chemical Investment Holding Corporation Maltodextrin-based adhesives
US5945126A (en) * 1997-02-13 1999-08-31 Oakwood Laboratories L.L.C. Continuous microsphere process
US5976586A (en) * 1997-03-10 1999-11-02 Lawrence Foods Glaze composition with vegetable gums
US6030641A (en) * 1997-06-03 2000-02-29 Uni Colloid Kabushiki Kaisha Sustained release capsule and method for preparing the same
US6063915A (en) * 1998-07-30 2000-05-16 Hercules Incorporated Carrageenan compositions and methods for their production
US6066368A (en) * 1997-12-30 2000-05-23 National Starch And Chemical Investment Holding Corporation Starch esters as moisture vapor barrier coatings
US6099876A (en) * 1994-10-11 2000-08-08 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Temperature-stable liquid cells
US6143324A (en) * 1998-02-03 2000-11-07 Cerestar Holdings B.V. Free-flowable directly compressible starch as binder, disintegrant and filler for compression tablets and hard gelatine capsules
US6146570A (en) * 1998-03-20 2000-11-14 Rhodia Inc. Process for producing extruded hydrocolloid granules
US6210709B1 (en) * 1999-03-24 2001-04-03 Elementis Specialties, Inc. Flexible gelatin free encapsulation material useful for pharmaceuticals, paint balls and other formulations
US6214376B1 (en) * 1998-08-25 2001-04-10 Banner Pharmacaps, Inc. Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture
US6326028B1 (en) * 1997-10-31 2001-12-04 Monsanto Company Alginate and gellan gum as tablet coating
US6331205B1 (en) * 1997-08-08 2001-12-18 Laurence Paris Aqueous viscous compositions, whether clear or not, for making soft or hard capsules, and method for making films for such capsules
US6340473B1 (en) * 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US6375981B1 (en) * 2000-06-01 2002-04-23 A. E. Staley Manufacturing Co. Modified starch as a replacement for gelatin in soft gel films and capsules
US6387354B1 (en) * 2000-03-06 2002-05-14 Shemberg Marketing Corporation Semi-refined carrageenan dentifrice binder
US20020122822A1 (en) * 2000-12-29 2002-09-05 Bunick Frank J. Process for preparing a soft tablet
US20020142031A1 (en) * 2000-06-01 2002-10-03 Gilleland G. M. Highly flexible starch-based films
US6479649B1 (en) * 2000-12-13 2002-11-12 Fmc Corporation Production of carrageenan and carrageenan products
US6517865B2 (en) * 1996-12-17 2003-02-11 Warner-Lambert Company Polymer film compositions for capsules
US20030085487A1 (en) * 2001-11-02 2003-05-08 Keith Tanner Apparatus and method for manufacturing encapsulated products
US20030084641A1 (en) * 2001-11-02 2003-05-08 Keith Tanner Encapsulation machine with valved injection wedge
US20030138482A1 (en) * 2002-01-18 2003-07-24 Fonkwe Linus G. Non-gelatin capsule shell formulation
US6607748B1 (en) * 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
US6635275B1 (en) * 1999-01-29 2003-10-21 Warner-Lambert Company Modified starch film compositions
US20030211146A1 (en) * 1998-09-30 2003-11-13 Scott Robert A. Modified starch film compositions
US20040052839A1 (en) * 2002-01-18 2004-03-18 Archibald Don A. Non-gelatin film and method and apparatus for producing same
US6790495B1 (en) * 1999-11-19 2004-09-14 Peter Greither Method for manufacturing a shape body containing a starch, a homogenised mass containing starch and a device for manufacturing a soft capsule
US20040180083A1 (en) * 2001-07-05 2004-09-16 Sumihiro Shiraishi Soft capsules
US20050037064A1 (en) * 2001-12-27 2005-02-17 Ulice And Pierre Fabre Medicament Heteroxylan film-forming composition for making capsules and resulting capsules
US20050069579A1 (en) * 2001-11-22 2005-03-31 Ryosei Kamaguchi Non-gelatinous capsule film compositions and capsules using the same
US20050070703A1 (en) * 2001-10-23 2005-03-31 Rolf Muller Polysaccharide based network and method for the production thereof
US20050089548A1 (en) * 2001-11-16 2005-04-28 Virgalitto Margaret T. Edible film
US20050163833A1 (en) * 2001-10-23 2005-07-28 Rolf Muller Production of starch-gel-based shaped bodies

Family Cites Families (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US348669A (en) 1886-09-07 John p
US3460717A (en) * 1967-10-16 1969-08-12 Burger Chef Systems Inc Mixing assembly for a dispenser
US3849395A (en) * 1971-08-25 1974-11-19 Marine Colloids Inc Degraded modified seaweed extractive and compositions containing same and their production
US4231803A (en) 1978-05-22 1980-11-04 Anheuser-Busch Incorporated Starch adhesive composition containing an oxidized waxy starch ester
JPS56167703A (en) * 1980-04-09 1981-12-23 Fmc Corp Sea weed eucheumacottonii denatured extract
JPS6055039A (en) * 1983-09-07 1985-03-29 Mitsubishi Acetate Co Ltd Water-soluble polysaccharide film
JPS6088047A (en) 1983-10-21 1985-05-17 Kohjin Co Ltd Preparation of highly absorptive polymer
JPS6110508A (en) * 1984-06-26 1986-01-18 Mitsubishi Acetate Co Ltd Capsule and its production
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
JPS63164858A (en) * 1986-12-27 1988-07-08 Unie Koroido Kk Outer coat of soft capsule
US4851394A (en) * 1986-12-30 1989-07-25 Uni Colloid Kabushiki Kaisha Glucomannan/polyhydric alcohol composition and film prepared therefrom
US4808707A (en) * 1987-06-08 1989-02-28 University Of Delaware Chitosan alginate capsules
JPS6416563A (en) * 1987-07-10 1989-01-20 Toyo Suisan Kaisha Production of sheet-shaped food
JPH0259513A (en) * 1988-08-24 1990-02-28 Kiyuukiyuu Yakuhin Kogyo Kk Oral cavity mucosa-attaching type halitosis-preventing agent
JPH02308760A (en) * 1989-05-23 1990-12-21 Mitsubishi Rayon Co Ltd Edible film and preparation thereof
PL285925A1 (en) 1989-07-11 1991-03-11 Warner Lambert Co Polymer mixture, method for manufacturing a thermoplastic product and a method for manufacturing a thermoplastic alloy
NO903089L (en) 1989-07-18 1991-01-21 Warner Lambert Co POLYMER BASIC MIXTURES WITH STRUCTURALLY CHANGED STARCH.
CA2020895C (en) 1989-07-18 2004-02-17 Jean-Pierre Sachetto Polymer base blend compositions containing destructurized starch
CA2021119C (en) 1989-07-20 2004-05-18 Jean-Pierre Sachetto Polymer base blend compositions containing destructurized starch
US5146730A (en) 1989-09-20 1992-09-15 Banner Gelatin Products Corp. Film-enrobed unitary-core medicament and the like
JPH0647530B2 (en) * 1990-02-03 1994-06-22 ユニコロイド株式会社 Pharmaceutical capsules for intestinal diseases and method for producing the same
DE4018247A1 (en) * 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts MANUFACTURING METHOD FOR QUICK-DISINFITTING FILM-SHAPED PHARMACEUTICAL FORMS
GB9017800D0 (en) 1990-08-14 1990-09-26 Unilever Plc Moisture barrier and its preparation
JPH04293460A (en) * 1991-03-20 1992-10-19 Mitsubishi Rayon Co Ltd Polysaccharide film and its production
JPH04372627A (en) * 1991-06-20 1992-12-25 Mitsubishi Rayon Co Ltd Polysaccharide film
EP0547551B1 (en) 1991-12-16 1997-11-05 National Starch and Chemical Investment Holding Corporation Edible films
JPH05308910A (en) * 1992-05-01 1993-11-22 Osaka Kagaku Gokin Kk Water-resistant edible film good in heat sealability
WO1993025193A1 (en) 1992-06-12 1993-12-23 Teijin Limited Pharmaceutical preparation for intra-airway administration
JPH0665048A (en) * 1992-08-20 1994-03-08 Kibun Food Chemifa Co Ltd Filmy pack agent
JP3116602B2 (en) * 1992-10-06 2000-12-11 シオノギクオリカプス株式会社 Hard capsule
GB9226392D0 (en) 1992-12-18 1993-02-10 Cpc International Inc Gelling agent
JPH07135913A (en) * 1993-11-19 1995-05-30 Sanei Gen F F I Inc Production of dessert jelly of multiple structure
JP2567566B2 (en) * 1994-03-01 1996-12-25 三栄源エフ・エフ・アイ株式会社 Drink jelly manufacturing method
US5528088A (en) * 1994-06-27 1996-06-18 Amphenol Corporation Current mode coupler with improved grounding
JP2959423B2 (en) 1994-12-01 1999-10-06 シオノギクオリカプス株式会社 Capsule coating composition
US5656294A (en) 1995-06-07 1997-08-12 Cibus Pharmaceutical, Inc. Colonic delivery of drugs
GB9606371D0 (en) 1996-03-26 1996-06-05 Brown Malcolm D An encapsulation process
US6214375B1 (en) * 1996-07-16 2001-04-10 Generex Pharmaceuticals, Inc. Phospholipid formulations
DE19646392A1 (en) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Preparation for use in the oral cavity with a layer containing pressure-sensitive adhesive, pharmaceuticals or cosmetics for dosed delivery
JPH10179045A (en) * 1996-12-25 1998-07-07 Osaka Kagaku Gokin Kk Sheet-like edible molding
US5813093A (en) * 1997-01-31 1998-09-29 Lucent Technologies Inc. Hinge assembly
JP3238350B2 (en) * 1997-05-27 2001-12-10 三粧化研株式会社 Edible pearl-like capsule and method for producing the same
JP2931811B2 (en) * 1997-06-03 1999-08-09 ユニコロイド株式会社 Sustained release capsule
JPH11130645A (en) * 1997-10-29 1999-05-18 Lion Corp Sheet for treatment of periodontosis
US5962053A (en) * 1998-02-17 1999-10-05 Viskase Corporation Edible film and method
US6187293B1 (en) 1998-04-27 2001-02-13 Fmc Corporation Process for making toothpaste using low levels of carrageenan
JP3182393B2 (en) * 1998-05-13 2001-07-03 三菱レイヨン株式会社 Carrageenan for low temperature gelation
KR20000011247A (en) * 1998-07-23 2000-02-25 김윤 Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides
US6268191B1 (en) * 1998-09-21 2001-07-31 Robert K. Prud'homme Enzyme immobilization by imbibing an enzyme solution into dehydrated hydrocolloid gel beads
US6596298B2 (en) * 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
US20030206942A1 (en) * 1998-09-25 2003-11-06 Neema Kulkarni Fast dissolving orally consumable films containing an antitussive and a mucosa coating agent
JP2000125801A (en) 1998-10-22 2000-05-09 Japan Tobacco Inc Granule of fushis
GB9824658D0 (en) * 1998-11-11 1999-01-06 Brown Malcolm D A capsule based drug delivery system
CA2348843A1 (en) 1998-11-11 2000-05-18 Edward Zbygniew Nowak A capsule based drug delivery system
US6432448B1 (en) * 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
NZ514994A (en) 1999-05-12 2003-05-30 Cp Kelco Aps Food composition with high solids content, a method for its preparation as well as the use of carrageenans for gelling a food composition
WO2001002478A1 (en) * 1999-07-06 2001-01-11 The Procter & Gamble Company Pre-formed, self-adhesive sheet devices suitable for topical application
US6500462B1 (en) * 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
EP1237561B2 (en) * 1999-12-09 2009-04-22 Comvita Limited Medical dressings comprising gelled honey
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
JP3481580B2 (en) * 2000-04-11 2003-12-22 三栄源エフ・エフ・アイ株式会社 Elastic food composition and method for producing the same
US6497887B1 (en) * 2000-04-13 2002-12-24 Color Access, Inc. Membrane delivery system
JP2004513144A (en) 2000-11-09 2004-04-30 セラニーズ ベンチャーズ ゲー・エム・ベー・ハー Soft capsules containing a starch mixture with reduced degree of branching
BR0115585A (en) * 2000-11-28 2005-12-13 Fmc Corp Ready-release, hardenable, edible, dry and wet coating compositions, solid dosage form and method for coating a pharmaceutical or veterinary solid dosage form, confectionery, seed, animal feed, fertilizer, pesticide tablet or food
US20020131990A1 (en) * 2000-11-30 2002-09-19 Barkalow David G. Pullulan free edible film compositions and methods of making the same
JP2002186427A (en) * 2000-12-19 2002-07-02 Sanei Gen Ffi Inc Frozen dessert
WO2002074100A1 (en) * 2001-03-19 2002-09-26 Taisho Pharmaceutical Co.,Ltd. Gel composition
US7293910B2 (en) * 2001-05-24 2007-11-13 Masco Corporation Surge suppressor for a mixer head assembly
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
AU2002332118B2 (en) * 2001-10-12 2008-06-26 Aquestive Therapeutics, Inc. Glucan based film delivery systems
JP2003125714A (en) * 2001-10-29 2003-05-07 Ina Food Ind Co Ltd Capsule base material and capsule made from the base material, and method for producing the capsule base material
JP2003192615A (en) * 2001-12-26 2003-07-09 Nissei Kosan Kk Method for producing capsule
JP2003199809A (en) * 2002-01-09 2003-07-15 Toyo Capsule Kk Soft capsule shell
NO20021592D0 (en) * 2002-04-04 2002-04-04 Fmc Biopolymer As Polysaccharide Capsules and Method of Preparation thereof
JP2003299714A (en) 2002-04-10 2003-10-21 Fuji Capsule Kk Film composition of soft capsule
JP4000279B2 (en) * 2002-05-29 2007-10-31 富士フイルム株式会社 Recording tape cartridge
US20040013723A1 (en) * 2002-07-16 2004-01-22 PARIKH Rita M. Oral care capsules
GB0217382D0 (en) * 2002-07-26 2002-09-04 Pfizer Ltd Process for making orally consumable dosage forms
JP2004167084A (en) 2002-11-21 2004-06-17 Ina Food Ind Co Ltd Soft capsule coating film, its raw material, and soft capsule
US6987182B2 (en) 2003-03-26 2006-01-17 North Carolina State University Process for producing cold-gelling hydrocolloids
US20040202698A1 (en) * 2003-04-02 2004-10-14 The Procter & Gamble Company Drug delivery systems comprising an encapsulated active ingredient
US20050013847A1 (en) * 2003-04-14 2005-01-20 Fmc Corporation Delivery systems of homogeneous, thermoreversible alginate films
US20050019294A1 (en) * 2003-04-14 2005-01-27 Fmc Corporation Homogeneous, thermoreversible alginate films and soft capsules made therefrom
US7816341B2 (en) * 2003-04-14 2010-10-19 Fmc Corporation Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom
US20050019295A1 (en) * 2003-04-14 2005-01-27 Fmc Corporation Homogeneous, thermoreversible low viscosity polymannan gum films and soft capsules made therefrom
KR20060011953A (en) * 2003-04-14 2006-02-06 에프엠씨 코포레이션 Process for making gel films
US20050048185A1 (en) * 2003-04-14 2005-03-03 Fmc Corporation Delivery systems of homogeneous, thermoreversible low viscosity polymannan gum films
US20050008677A1 (en) * 2003-04-14 2005-01-13 Fmc Corporation Delivery system of homogeneous, thermoreversible gel film containing kappa-2 carrageenan

Patent Citations (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2813093A (en) * 1953-06-10 1957-11-12 Nat Starch Products Inc Ungelatinized tertiary amino alkyl ethers of amylaceous materials
US2802000A (en) * 1953-08-13 1957-08-06 Nat Starch Products Inc Ungelatinized cold water soluble starch ethers
US2825727A (en) * 1954-05-19 1958-03-04 Nat Starch Products Inc Ungelatinized starch products of improved properties and method of making the same
US2876217A (en) * 1956-12-31 1959-03-03 Corn Products Co Starch ethers containing nitrogen and process for making the same
US3094517A (en) * 1958-12-29 1963-06-18 Marine Colloids Inc Process for treating a polysaccharide of seaweeds of the gigartinaceae and solieriaceae families
US3329509A (en) * 1959-12-01 1967-07-04 Ile Des Produits Lifine Soc Ci Food wrapping membrane
US3058827A (en) * 1960-02-09 1962-10-16 Eastman Kodak Co Dialdehyde starch as gelatin hardener
US3176003A (en) * 1961-08-15 1965-03-30 Marine Colloids Inc Selective extraction of hydrocolloid fractions from sea plants
US3378546A (en) * 1965-03-03 1968-04-16 American Maize Prod Co Hydroxypropyl starch ether
US3505110A (en) * 1967-01-18 1970-04-07 Penick & Ford Ltd Sugar products prepared from hydroxypropylated starch
US3499962A (en) * 1967-08-24 1970-03-10 Nat Starch Chem Corp Encapsulation of water insoluble materials
US3607394A (en) * 1969-05-29 1971-09-21 Felix Joseph Germino Novel pregelatinized starches and process for preparing same
US3865603A (en) * 1972-07-17 1975-02-11 Nat Starch Chem Corp Modified starch-extended gelatin compositions
US4009291A (en) * 1974-03-25 1977-02-22 General Foods Corporation Cold water soluble stable bulked starch
US3956173A (en) * 1974-07-05 1976-05-11 Hercules Incorporated Preparation of gels based on carrageenan
US3962482A (en) * 1975-03-24 1976-06-08 Uniroyal, Ltd. Clear, elastic, water gels based on carrageenan
US4129134A (en) * 1975-04-14 1978-12-12 Philip Morris Incorporated Smoking article
US4026986A (en) * 1975-05-22 1977-05-31 The Dow Chemical Company Capsule shell
US4096327A (en) * 1977-01-05 1978-06-20 Fmc Corporation Modified kappa-carrageenan
US4276320A (en) * 1980-01-25 1981-06-30 Fmc Corporation Compositions and method for preparing dessert gels
US4443486A (en) * 1980-04-09 1984-04-17 Fmc Corporation Modified extractive of Eucheuma cottonii seaweed and composition containing same
US4632848A (en) * 1981-06-23 1986-12-30 Roquette Freres Composition and process for forming a temporary protective coating on an article and article so-protected
US4600439A (en) * 1982-10-12 1986-07-15 Roquette Freres Composition and process for coating paper and cardboard process for preparing the compositions and paper and cardboard so obtained
US4738724A (en) * 1983-11-04 1988-04-19 Warner-Lambert Company Method for forming pharmaceutical capsules from starch compositions
US4643894A (en) * 1984-07-24 1987-02-17 Colorcon, Inc. Maltodextrin coating
US4725441A (en) * 1984-07-24 1988-02-16 Colorcon, Inc. Maltodextrin coating
US4828841A (en) * 1984-07-24 1989-05-09 Colorcon, Inc. Maltodextrin coating
US4626288A (en) * 1985-01-10 1986-12-02 National Starch And Chemical Corporation Starch derivatives forming reversible gels
US4615897A (en) * 1985-02-25 1986-10-07 Nabisco Brands, Inc. Cold water soluble gelatin
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
US5002934A (en) * 1986-11-24 1991-03-26 Van Den Bergh Foods Co., Division Of Conopco, Inc. Aqueous gel comprising carrageenan
US5051304A (en) * 1986-12-18 1991-09-24 Societe Anonyme: Mero Rousselot Satia Microcapsules based on gelatin and polysaccharides and process for obtaining same
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5525368A (en) * 1989-02-10 1996-06-11 Alko Group Ltd. Degraded polysaccharide derivatives and foodstuffs containing same
US5089307A (en) * 1989-05-23 1992-02-18 Mitsubishi Rayon Co., Ltd. Edible film and method of making same
US5620757A (en) * 1989-05-23 1997-04-15 Mitsubishi Rayon Co., Ltd. Edible film and method of making same
US5264223A (en) * 1990-03-29 1993-11-23 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5554385A (en) * 1990-11-28 1996-09-10 R. P. Scherer Corporation High amylose starch substituted gelatin capsules
US5224989A (en) * 1991-11-18 1993-07-06 Eva Likarova Film-forming dispersion for a protective coating of drug and food containing articles and objects
US5587412A (en) * 1992-03-31 1996-12-24 National Starch And Chemical Investment Holding Corporation Esterified starch composition
US5334640A (en) * 1992-04-08 1994-08-02 Clover Consolidated, Ltd. Ionically covalently crosslinked and crosslinkable biocompatible encapsulation compositions and methods
US5550178A (en) * 1992-04-08 1996-08-27 Vivorx, Inc. Process for encapsulating biologics using crosslinkable biocompatible encapsulation system
US5484598A (en) * 1992-08-18 1996-01-16 R.P. Scherer Corporation Soft gelatin medicament capsules with gripping construction
US5431917A (en) * 1992-10-08 1995-07-11 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5646206A (en) * 1993-04-23 1997-07-08 The United States Of America As Represented By The Secretary Of Agriculture Films fabricated from mixtures of pectin and poly(vinyl alchohol)
US5451673A (en) * 1993-04-23 1995-09-19 The United States Of America As Represented By The Secretary Of Agriculture Films fabricated from mixtures of pectin and starch
US5342626A (en) * 1993-04-27 1994-08-30 Merck & Co., Inc. Composition and process for gelatin-free soft capsules
US5817323A (en) * 1993-06-28 1998-10-06 R.P. Scherer Corporation Soft gelatin capsule shell compositions
US6099876A (en) * 1994-10-11 2000-08-08 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Temperature-stable liquid cells
US5756123A (en) * 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
US5804243A (en) * 1994-12-23 1998-09-08 Cpc International Inc. Process for making low-fat, cake donuts
US5569466A (en) * 1995-05-17 1996-10-29 R. P. Scherer Corporation Fill compositions for soft elastic gel capsules
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
US5614217A (en) * 1995-06-07 1997-03-25 R.P. Scherer Corporation Capsule shell formulation to produce brittle capsules
US5672699A (en) * 1995-09-06 1997-09-30 National Starch And Chemical Investment Holding Corporation Process for preparation of hydrophobic starch derivatives
US5549983A (en) * 1996-01-22 1996-08-27 Alliedsignal Inc. Coflow planar fuel cell stack construction for solid electrolytes
US5932639A (en) * 1996-05-06 1999-08-03 National Starch And Chemical Investment Holding Corporation Maltodextrin-based adhesives
US5820259A (en) * 1996-07-30 1998-10-13 Q-Jet Dsi, Inc. Dual control mixing jet cooker
US5726008A (en) * 1996-09-18 1998-03-10 Eastman Kodak Company Photographic elements with improved vehicles
US6517865B2 (en) * 1996-12-17 2003-02-11 Warner-Lambert Company Polymer film compositions for capsules
US5945126A (en) * 1997-02-13 1999-08-31 Oakwood Laboratories L.L.C. Continuous microsphere process
US5976586A (en) * 1997-03-10 1999-11-02 Lawrence Foods Glaze composition with vegetable gums
US6030641A (en) * 1997-06-03 2000-02-29 Uni Colloid Kabushiki Kaisha Sustained release capsule and method for preparing the same
US6331205B1 (en) * 1997-08-08 2001-12-18 Laurence Paris Aqueous viscous compositions, whether clear or not, for making soft or hard capsules, and method for making films for such capsules
US6326028B1 (en) * 1997-10-31 2001-12-04 Monsanto Company Alginate and gellan gum as tablet coating
US6066368A (en) * 1997-12-30 2000-05-23 National Starch And Chemical Investment Holding Corporation Starch esters as moisture vapor barrier coatings
US6143324A (en) * 1998-02-03 2000-11-07 Cerestar Holdings B.V. Free-flowable directly compressible starch as binder, disintegrant and filler for compression tablets and hard gelatine capsules
US6146570A (en) * 1998-03-20 2000-11-14 Rhodia Inc. Process for producing extruded hydrocolloid granules
US6063915A (en) * 1998-07-30 2000-05-16 Hercules Incorporated Carrageenan compositions and methods for their production
US6214376B1 (en) * 1998-08-25 2001-04-10 Banner Pharmacaps, Inc. Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture
US20030211146A1 (en) * 1998-09-30 2003-11-13 Scott Robert A. Modified starch film compositions
US6635275B1 (en) * 1999-01-29 2003-10-21 Warner-Lambert Company Modified starch film compositions
US6210709B1 (en) * 1999-03-24 2001-04-03 Elementis Specialties, Inc. Flexible gelatin free encapsulation material useful for pharmaceuticals, paint balls and other formulations
US6340473B1 (en) * 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US20020081331A1 (en) * 1999-07-07 2002-06-27 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US6582727B2 (en) * 1999-07-07 2003-06-24 R. P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US6790495B1 (en) * 1999-11-19 2004-09-14 Peter Greither Method for manufacturing a shape body containing a starch, a homogenised mass containing starch and a device for manufacturing a soft capsule
US6387354B1 (en) * 2000-03-06 2002-05-14 Shemberg Marketing Corporation Semi-refined carrageenan dentifrice binder
US6528088B1 (en) * 2000-06-01 2003-03-04 A. E. Staley Manufacturing Co. Highly flexible starch-based films
US6375981B1 (en) * 2000-06-01 2002-04-23 A. E. Staley Manufacturing Co. Modified starch as a replacement for gelatin in soft gel films and capsules
US6649188B2 (en) * 2000-06-01 2003-11-18 A. E. Staley Manufacturing Co. Highly flexible starch-based films
US20020142031A1 (en) * 2000-06-01 2002-10-03 Gilleland G. M. Highly flexible starch-based films
US6607748B1 (en) * 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
US6479649B1 (en) * 2000-12-13 2002-11-12 Fmc Corporation Production of carrageenan and carrageenan products
US20020122822A1 (en) * 2000-12-29 2002-09-05 Bunick Frank J. Process for preparing a soft tablet
US20040180083A1 (en) * 2001-07-05 2004-09-16 Sumihiro Shiraishi Soft capsules
US20050163833A1 (en) * 2001-10-23 2005-07-28 Rolf Muller Production of starch-gel-based shaped bodies
US20050070703A1 (en) * 2001-10-23 2005-03-31 Rolf Muller Polysaccharide based network and method for the production thereof
US20030084641A1 (en) * 2001-11-02 2003-05-08 Keith Tanner Encapsulation machine with valved injection wedge
US20030085487A1 (en) * 2001-11-02 2003-05-08 Keith Tanner Apparatus and method for manufacturing encapsulated products
US20050089548A1 (en) * 2001-11-16 2005-04-28 Virgalitto Margaret T. Edible film
US20050069579A1 (en) * 2001-11-22 2005-03-31 Ryosei Kamaguchi Non-gelatinous capsule film compositions and capsules using the same
US20050037064A1 (en) * 2001-12-27 2005-02-17 Ulice And Pierre Fabre Medicament Heteroxylan film-forming composition for making capsules and resulting capsules
US20040052839A1 (en) * 2002-01-18 2004-03-18 Archibald Don A. Non-gelatin film and method and apparatus for producing same
US20030138482A1 (en) * 2002-01-18 2003-07-24 Fonkwe Linus G. Non-gelatin capsule shell formulation

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050196437A1 (en) * 2004-03-02 2005-09-08 Bednarz Christina A. Hard capsules
US20050196436A1 (en) * 2004-03-02 2005-09-08 Arjnarong Chantranukul Blends of different acyl gellan gums and starch
US7494667B2 (en) 2004-03-02 2009-02-24 Brunob Ii B.V. Blends of different acyl gellan gums and starch
US8262820B2 (en) 2006-04-28 2012-09-11 United States Gypsum Company Method of water dispersing pregelatinized starch in making gypsum products
US20080138402A1 (en) * 2006-11-17 2008-06-12 Zhixin Li Highly inhibited starch fillers for films and capsules
US8574624B2 (en) 2006-11-17 2013-11-05 Corn Products Development, Inc. Highly inhibited starch fillers for films and capsules
US20090217462A1 (en) * 2008-02-08 2009-09-03 Holzhauer Fred Consumer product packets with enhanced performance
US8236747B2 (en) 2008-02-08 2012-08-07 Method Products, Inc. Consumer product packets with enhanced performance
US20090249562A1 (en) * 2008-04-02 2009-10-08 Mark Robert Sivik Fabric color rejuvenation composition
US20100061180A1 (en) * 2008-09-05 2010-03-11 United States Gypsum Company Efficient wet starch preparation system for gypsum board production
US8303159B2 (en) 2008-09-05 2012-11-06 United States Gypsum Company Efficient wet starch preparation system for gypsum board production

Also Published As

Publication number Publication date
WO2004091527A2 (en) 2004-10-28
EP1617825A2 (en) 2006-01-25
KR20060011955A (en) 2006-02-06
WO2004091530B1 (en) 2005-04-21
WO2004091538A3 (en) 2005-04-07
BRPI0409357B1 (en) 2018-02-06
JP2007525551A (en) 2007-09-06
JP2006524743A (en) 2006-11-02
WO2004091533A3 (en) 2006-05-18
EP1628643A2 (en) 2006-03-01
EP1617815A2 (en) 2006-01-25
PL1628643T3 (en) 2013-09-30
EP1622594A2 (en) 2006-02-08
JP2007528357A (en) 2007-10-11
CA2522296A1 (en) 2004-10-28
BRPI0409342A (en) 2006-04-25
EP1628643A4 (en) 2010-01-06
KR20060003350A (en) 2006-01-10
JP2007526211A (en) 2007-09-13
WO2004091539A2 (en) 2004-10-28
BRPI0409345A (en) 2006-04-25
WO2004091529B1 (en) 2005-05-19
WO2004091529A2 (en) 2004-10-28
WO2004091537B1 (en) 2005-07-14
WO2004091527B1 (en) 2005-10-06
JP4558721B2 (en) 2010-10-06
KR20060011953A (en) 2006-02-06
KR101128201B1 (en) 2012-03-23
WO2004091528B1 (en) 2005-03-24
WO2004091530A2 (en) 2004-10-28
WO2004091528A3 (en) 2005-01-27
BRPI0409357A (en) 2006-04-25
WO2004091533A2 (en) 2004-10-28
CA2522297A1 (en) 2004-10-28
JP4602326B2 (en) 2010-12-22
JP2006526057A (en) 2006-11-16
CA2522295A1 (en) 2004-10-28
MXPA05011028A (en) 2005-12-12
IL171291A (en) 2010-12-30
JP2007525451A (en) 2007-09-06
EP1628620A4 (en) 2010-01-06
BRPI0409329A (en) 2006-04-25
EP1620059A2 (en) 2006-02-01
CA2522295C (en) 2012-02-07
US20050019374A1 (en) 2005-01-27
WO2004091538A2 (en) 2004-10-28
MXPA05011027A (en) 2005-12-12
US20080089934A1 (en) 2008-04-17
MXPA05011026A (en) 2005-12-12
EP1628620A2 (en) 2006-03-01
WO2004091532A3 (en) 2006-05-18
US7807194B2 (en) 2010-10-05
EP1628643B9 (en) 2013-06-12
EP1628643B1 (en) 2013-02-27
BRPI0409334A (en) 2006-04-25
WO2004091528A2 (en) 2004-10-28
JP2007526210A (en) 2007-09-13
WO2004091527A3 (en) 2005-08-18
WO2004091532A2 (en) 2004-10-28
CA2522298A1 (en) 2004-10-28
WO2004091537A2 (en) 2004-10-28
EP1622594A4 (en) 2010-07-14
WO2004091537A3 (en) 2005-05-06
WO2004091538B1 (en) 2005-05-26
EP1620114A2 (en) 2006-02-01
BRPI0409336A (en) 2006-04-25
JP2007526209A (en) 2007-09-13
MXPA05011029A (en) 2005-12-12
EP1622588A2 (en) 2006-02-08
WO2004091529A3 (en) 2005-02-24
BRPI0409343A (en) 2006-04-25
WO2004091530A3 (en) 2005-03-03
CA2522293A1 (en) 2004-10-28
WO2004091539A3 (en) 2005-05-06
BRPI0409357B8 (en) 2021-05-25
KR20060011954A (en) 2006-02-06

Similar Documents

Publication Publication Date Title
US20050084516A1 (en) Process for making gel films
US7816341B2 (en) Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom
US20090208569A1 (en) Homogeneous, Thermoreversible Alginate Films and Soft Capsules Made Therefrom
ZA200508251B (en) Homogeneous, thermoreversible gel film containing kappa-2 carrageenan and soft capsules made therefrom
US20050013847A1 (en) Delivery systems of homogeneous, thermoreversible alginate films
US20050008677A1 (en) Delivery system of homogeneous, thermoreversible gel film containing kappa-2 carrageenan
US20050019295A1 (en) Homogeneous, thermoreversible low viscosity polymannan gum films and soft capsules made therefrom
RU2341250C2 (en) Homogeneous thermal reversible gel film containing cappa-2-carraginan, and soft capsules produced thereof
RU2341290C2 (en) Homogeneous, thermally reversible gel containing carragenan of underviscosity, and products made thereof
ZA200508253B (en) Homogeneous, thermoreversible alginate films and soft capsules made therefrom

Legal Events

Date Code Title Description
AS Assignment

Owner name: FMC CORPORATION, PENNSYLVANIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BALLARD, ARTHUR D.;SEWALL, CHRISTOPHER J.;MODLISZEWSKI, JAMES J.;AND OTHERS;REEL/FRAME:018278/0838;SIGNING DATES FROM 20040805 TO 20040810